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ABSTRACT 
 
 The majority of the populations in the developing world rely on traditional 
medicine for their primary healthcare needs. Herbal therapy predominates in traditional 
medicine as well as in complementary or alternative medicine practiced in the developed 
world. Among the various indications where traditional herbal medicines are used, skin 
and skin related disorders are ranked top. Thus, the main objective of the present study is 
to formulate and evaluate semi-solid dosage forms of Hypericum mysorense for its 
wound healing activity. 
 The stem of Hypericum mysorense was extracted by continuous hot percolation/ 
soxhletation using methanol as solvent and was evaluated for its phytochemical property, 
in-vitro antimicrobial and in-vitro antioxidant activity. Using this methanolic extract, 
semi-solid dosage form(ointment) was formulated. Ointment was prepared using 2% 
concentration of the extract by fusion method using emulsifying ointment as base and 
then tested for physiochemical properties like colour, loss on drying, pH, viscosity, 
melting point, spreadability and extrudability. HPTLC analysis, in-vitro diffusion studies, 
kinetic studies and stability studies were also conducted on the preparation. The results of 
in-vitro antimicrobial and in-vitro antioxidant activity added on to the wound healing 
activity of the extract. Hence, the ointment containing 2% methanolic extract of 
Hypericum mysorense was evaluated for its wound healing activity using excision wound 
model. The formulation did not produce any skin irritation for about a week when applied 
over the skin. The effect produced by the extract ointment, in terms of wound contracting 
ability, wound closure time and histopathological characteristics were comparable to that 
of a standard drug, povidone iodine ointment. Therefore, the present study concluded that 
the Hypericum mysorense at 2% concentration of the methanolic extract formulated as an 
ointment showed a better wound healing formulation for better patient care and pharmaco 
economical.  
 
Keywords: Hypericum mysorense, Excision wound model, ointment, in-vitro 
antimicrobial, in-vitro antioxidant 
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INTRODUCTION 
OVERVIEW OF TRADITIONAL HERBAL MEDICINE1: 
India is a birthplace of indigenous medicine such as Siddha, Ayurveda, and Unani 
where many herbs have been used for treatment of human ailments. About 65% of total 
global population remains dependent on traditional medicines for their primary 
healthcare. Herbs are occupying a comeback and an ‘Herbal Renaissance’ is blooming 
across the world. They have been evidently prized for their medicinal, flavoring and 
aromatic qualities for centuries, yet for a while they were over shadow by synthetic 
products of modern civilization. Folk medicine is generally defined as traditional 
medicine that is practiced by non-professional healers or embodied in local custom or 
lore, generally involving the use of natural and especially herbal remedies. The World 
Health Organization (WHO) defines traditional medicine as “the health practices, 
approaches, knowledge and beliefs incorporating plant, animal and mineral-based 
medicines, spiritual therapies, manual techniques and exercise, applied singularly or in 
combination to treat, diagnose and prevent illnesses or maintain well-being.” Treatments 
are specific to a particular ailment and may include the power of rare, dancing, sweet 
baths, massage, medicinal herbs, hot and cold foods or other means not practiced in 
modern medicine. 
Once having realized their sources and adverse effects, people are going back to 
nature with hopes of safety and security. The rich treasure of herbal drugs is forming a 
boon for our society. Plant derived compounds, apart from their nutritive values, could 
serve as important therapeutic weapons to fight various human and animal diseases, 
thereby making them indispensable in traditional medicine for treating a number of 
diseases. Plant drugs, popularly known as herbal medicines have since been unabatedly 
used to treat various diseases. The major challenge is to protect traditional knowledge and 
will prove to be a beneficial asset to our human surrounding. For all the ailments herbal 
formulations are proved to be effective without any side effects commonly seen with 
allopathic drugs. 
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OINTMENT2 
An ointment is a homogeneous, viscous, semi-solid preparation, most commonly 
greasy, thick oil (oil 80% - water 20%) with a high viscosity which is intended for 
external application to the skin or mucous membranes. Ointments have a water 
number that defines the maximum amount of water that it can contain. They are used 
as emollients or for the application of active ingredients to the skin for protective, 
therapeutic, or prophylactic purposes and where a degree of occlusion is desired. 
Ointments are used topically on a variety of body surfaces. These include the skin and 
the mucous membranes of the eye (an eye ointment), vagina ,anus, and nose. An ointment 
may or may not be medicated. 
Ointments are usually very moisturizing, and good for dry skin. They have a low 
risk of sensitization due to having few ingredients beyond the base oil or fat, and low 
irritation risk. There is typically little variability between brands of generics and name 
brand drugs. They are often disliked by patients due to greasiness. 
 
OINTMENT BASE3:  
The vehicle of an ointment is known as the ointment base. The choice of a base 
depends upon the clinical indication for the ointment. There are five classes or types of 
ointment bases which are differentiated on the basis of their physical composition. These 
are: 
 oleaginous bases 
 absorption bases 
 water in oil emulsion bases 
 oil in water emulsion bases 
 water soluble or water miscible bases 
Each ointment base type has different physical characteristics and therapeutic uses 
based upon the nature of its components which is summarized in the table below. 
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                  SUMMARY CHART: PROPERTIES OF OINTMENT BASES 
 
  Oleaginous 
ointment 
bases 
Absorption 
ointment bases 
Water/Oil 
Emulsion 
ointment bases 
Oil/Water 
Emulsion 
ointment bases 
Water-
miscible 
ointment 
bases 
Composition oleaginous 
compounds 
oleaginous 
base + w/o 
surfactant 
oleaginous base 
+ water  
(< 45% w/w) + 
w/o surfactant 
(HLB <8) 
oleaginous 
base + water (> 
45% w/w) + 
o/w surfactant 
(HLB >9) 
Polyethylene 
Glycols 
(PEGs) 
 
Water 
Content 
Anhydrous Anhydrous Hydrous Hydrous anhydrous, 
hydrous 
Affinity for 
Water 
Hydrophobic Hydrophilic Hydrophilic Hydrophilic Hydrophilic 
Spreadability Difficult Difficult Moderate to easy Easy Moderate to 
easy 
Washability Nonwashable Nonwashable non- or poorly 
washable 
Washable Washable 
Stability oils poor; 
hydrocarbons 
better 
oils poor; 
hydrocarbons 
better 
unstable, 
especially alkali 
soaps and natural 
colloids 
unstable, 
especially 
alkali soaps 
and natural 
colloids; 
nonionic better 
Stable 
Drug 
Incorporation 
Potential 
solids or oils 
(oil soluble 
only) 
solids, oils, and 
aqueous 
solutions 
(small 
amounts) 
solids, oils, and 
aqueous 
solutions (small 
amounts) 
solid and 
aqueous 
solutions 
(small 
amounts) 
solid and 
aqueous 
solutions 
Drug Release 
Potential* 
Poor poor, but > 
oleaginous 
fair to good fair to good Good 
Occlusiveness Yes Yes sometimes No No 
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METHODS OF PREPARATION OF OINTMENT: 
o Trituration: In this method, finely subdivided insoluble medicaments are evenly 
distributed by grinding with a small amount of the base followed by dilution with 
gradually increasing amounts of the base. 
o Fusion: In this method, the ingredients are melted together in descending order of 
their melting points and stirred to ensure homogeneity. 
 
EVALUATION OF OINTMENT: 
1. Colour and odour 
2. Loss on drying 
3. pH 
4. Spreadability 
5. Extrudability 
Uses protectants, 
emollients (+/-
), vehicles for 
hydrolysable 
drugs 
protectants, 
emollients (+/-
), vehicles for 
aqueous 
solutions, 
solids, and 
non-
hydrolysable 
drugs 
emollients, 
cleansing 
creams, vehicles 
for solid, liquid, 
or non-
hydrolysable 
drugs 
 
emollients, 
vehicles for 
solid, liquid, or 
non-
hydrolysable 
drugs 
drug vehicles 
Examples White 
Petrolatum, 
White 
Ointment 
Hydrophilic 
Petrolatum, 
Anhydrous 
Lanolin, 
Aquabase™, 
Aquaphor®, 
Polysorb® 
Cold Cream type, 
Hydrous Lanolin, 
Rose Water 
Ointment, 
Hydrocream™, 
Eucerin®, 
Nivea® 
Hydrophilic 
Ointment, 
Dermabase™, 
Velvachol®, 
Unibase® 
PEG 
Ointment, 
Polybase™ 
*Varies depending upon specific content of the ointment base and the relative polarity of the 
drug(s) incorporated. This table refers more generally to the release of a typical nonelectrolyte 
(primarily lipophilic) drug. 
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6. Diffusion Study 
7. Stability Study 
 IN-VITRO DIFFUSION STUDY: 
The in-vitro permeation study was carried out by using excised rat abdominal skin 
and franz diffusion cell. The skin was sandwiched between donor and receptor 
compartments of the diffusion cell. A 2.2 cm diameter patch was placed in intimate 
contact with the stratum corneum side of the skin; the top side was covered with 
aluminium foil as a backing membrane. Teflon bead was placed in the receptor 
compartment filled with 12ml of normal saline. The cell contents were stirred with a 
magnetic stirrer and a temperature of 37 ± 5°C was maintained throughout the 
experiment. Samples of 1ml were withdrawn through the sampling port at different time 
intervals for a period of 24 hours, simultaneously replacing equal volume by phosphate 
buffer pH 7.4 after each withdrawal. Then the samples were analyzed by 
spectrophotometrically. 
 
OINTMENT APPLICATIONS: 
There are various parts of the body surfaces, skin and mucous membranes where 
ointment is applied for curing certain skin or disease conditions. Ointment is applied on 
hands, legs, face, eyes, ears, vagina, anus, throat etc. There are various problems when an 
ointment is suggested for treatment such as 
 Ointment for burns 
 Ointments for cuts 
 Ointments for pain 
 Ointments for itching 
 Ointments for inflammation and pain 
 Ointments for boils and scars 
 Ointments for skin problems like eczema, dermatitis and psoriasis  
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CONTAINERS: 
Ointments are packaged either in ointment jars or tubes.  The ointment jars are 
usually straight-sided screw cap jars of glass or plastic.  The ointment should be packed 
while it is still warm and fluid by either pouring it directly into the jar or packaging it by 
pressure with a spatula.  Ointment jars hand-filled by the pharmacist should also be 
finished to avoid contact between the ointment and the cap.  This can be accomplished by 
forcing a spatula across the ointment jar while depressed slightly in the ointment.  
  
Ordinary tin tubes are used for packaging ointments if the ointment is not too 
stiff.  These tubes are available in various sizes complete with ophthalmic, rectal, vaginal, 
or plain tips.  Tubes are usually filled at the prescription counter by rolling the ointment 
into a cylinder in a piece of parchment paper in such a way that it can be inserted into the 
tube.  The paper can be removed by carefully flattening the open end of the tube against 
the paper and withdrawing it while firmly holding the end of the tube together.  It is 
usually necessary to remove the cap of the tube while filling to avoid air pockets in the 
tube. 
 
ANTIMICROBIAL THERAPY4 
There is a growing awareness of active contribution of the environment of context 
of infection. The nature of micro organism and many occasions on which they come into 
contact with humans, while others go on to produce diseases, lies in the nature of 
interaction between the microbe and host. The basis of antimicrobial therapy is to arrest 
the growth of the infecting micro organism and where possible to kill it without damage 
to patient. Once the decision to treat infection has been taken, the formulation has been 
formulated it is necessary to predict the micro organism. Antimicrobial agent’s 
particularly antibacterial agents can be effective against a wide range of micro organism. 
 
Bacterial skin infections can be distinguished by clinical examination and simple 
laboratory investigations. These are very common; they range from annoying to deadly. 
Most bacterial infections of the skin are caused by Staphylococcal aureus, Streptococcus 
and Pseudomonas aeruginosa. Staphylococcal aureus bacteria are classified as gram 
positive cocci based on their appearance under a microscope. They may occur singly or 
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grouped in pairs, short chains or grape-like clusters. They are only able to invade via 
broken skin or mucous membranes; hence intact skin is an excellent human defence. 
Once they have invaded they  have various ways to avoid host defense. They : 
 Hide their antigen to avoid an immune response 
 Kill infection- fighting cells ( phagocytes) 
 Survive within host infection- fighting cells 
 Develop resistance to antibiotics. 
 
MANAGEMENT OF BACTERIAL SKIN INFECTIONS: 
 Appropriate antibiotics 
 Drainage of pus collections 
 Surgical removal ( debridement) of dead tissue (necrosis) 
 Removal of foreign bodies (eg. Stitches) that may be a focus 
of persisting infection 
Due to widespread antibiotic resistance, it is better to prevent Staphylococcal 
infections wherever possible. The most effective way is to wash hands before touching 
broken skin. Various antibiotics are used depending upon site and severity of infection 
and susceptibility testing. It is also important to clear bacteria colonizing the nostrils and 
under the finger nails with either antibiotic ointment (e.g. fusidic acid or mupirocin) or 
petroleum jelly several times daily for one week of each month. The algorithm presented 
provides an approach to diagnosis and treatment. 
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Figure1.Algorithm showing approach to diagnosis and treatment            
 
 
ANTIOXIDANT ACTIVITY5: 
An antioxidant is a molecule capable of inhibiting the oxidation of other 
molecules. Oxidation is a chemical reaction that transfers electrons from a substance to 
an oxidizing agent. Oxidation reaction can produce free radicals. In turn, these radicals 
can start chain reactions that damage cells. Antioxidants terminate these chain reactions 
by removing free radical intermediates, and inhibit other oxidation reactions. They do this 
by being oxidized themselves, so antioxidants are often reducing agents such as thiols, 
ascorbic acid or polyphenols. 
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Reactive oxygen species (ROS), sometimes called active oxygen species, are 
various forms of activated oxygen, which include free radicals such as superoxide ions 
(O2) and hydroxyl radicals (OH) as well as non free-radical species such as hydrogen 
peroxide(H2O2). In living organisms various ROS can form in different ways, including 
normal aerobic respiration stimulated polymorphonuclear leukocytes and macrophages, 
and peroxisomes. These appear to be the main endogenous source of most of the oxidants 
produced by cells. Exogenous sources of free radical include tobacco smoke, ionizing 
radiation, certain pollutants, organic solvents and pesticides. Free radicals can cause lipid 
peroxidation in foods, which leads to their deterioration. In addition, reactive oxygen 
species have been implicated in more than 100 diseases, including malaria, AIDS, heart 
diseases, stroke, atherosclerosis, diabetes and cancer. When produced in excess, ROS can 
cause tissue injury). In a normal cell, there are appropriate oxidants: antioxidant balance. 
However, this balance can be shifted, when production species is increased or when 
levels of antioxidants are diminished. This stage is called oxidative stress. Oxidative 
stress results in the damage of biopolymers including nucleic acid, proteins, 
polyunsaturated fatty acid and carbohydrates. Lipid per oxidation is oxidative detoriation 
of polyunsaturated lipids and it involves ROS and transition metal ions. It is a molecular 
mechanism of cell injury leading yield a wide range of cytotoxic products, most of which 
are aldehyde, like malondialdehyde. Oxidative stress causes serious cell damage leading 
to variety of human diseases like Alzheimer’s disease, Parkinson’s disease, Arthritis and 
neuron de generative disorder etc. However, tissue injury can itself cause ROS 
generation. Nevertheless, all aerobic organisms, including human beings, have 
antioxidant defences that protect against oxidative damages, and numerous damage 
removal and repair enzymes to remove or repair damaged molecules. However, this 
natural antioxidant mechanism can be inefficient, and hence dietary intake of antioxidant 
compounds is important. There are some synthetic antioxidant compounds such as 
butylated hydroxyl toluene (BHT) and butylated hydroxyl anisole(BHA), commonly used 
in processed foods. 
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Figure 2: Mechanism of Antioxidant 
 
IN-VITRO DETERMINATION OF ANTI OXIDANT CAPACITY 
This approach has benefits over simply quantifying antioxidant components as it 
provides a measure of their effectiveness. The various conventional and latest methods 
come under in-vitro methods. It is very difficult to select a suitable anti oxidant assay 
method. Antioxidant act by several mechanisms and no one assay can capture the 
different modes of action of antioxidant. Conventional cuvette assay of radical 
scavenging activity is replaced by 96-well plate titer assay from past couple of years. 
Cuvette assay method uses UV-visible spectrophotometer to see the absorbance, where as 
96-well plate method uses ELISA plate reader for absorbance. 
 
WOUND HEALING ACTIVITY6: 
Wounds are inescapable events in life. Wounds may arise due to physical, 
chemical or microbial agents. Wound healing involves a complex series of interactions 
between different cell types, cytokine mediators, and the extracellular matrix. The phases 
of normal wound healing include hemostasis, inflammation, proliferation and 
remodeling. Each phase of wound healing is distinct, although the wound healing process 
is continous, with each phase overlapping the next. Because successful wound healing 
requires adequate blood and nutrients to be supplied to the site of damaged tissue. 
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CLASSIFICATION OF WOUNDS: 
Wounds are classified as open wounds and closed wounds on the basis of 
underlying cause of wound creation and as acute and chronic wounds on the basis of 
physiology of wound healing 
 
(a)  Open Wound7: 
Though an open wound blood escapes the body and bleeding is clearly visible. 
Open wound is further classified as: 
 
 Incised Wound: 
It is an injury with no tissue loss and minimal tissue damage. It is caused 
by a sharp object such as knife. Bleeding in such cases can be profuse, so 
immediate action should be taken. 
 
 Abrasions or Superficial Wounds: 
It is caused by sliding fall onto a rough surface. During abrasion the 
topmost layer of the skin i.e. epidermis is scraped off that exposes nerve ending 
resulting in a painful injury. Blood loss similar to a burn can result from serious 
abrasions. 
 
 Laceration Wound or Tears Wounds: 
This is the nonsurgical injury in conjunction with some type of trauma, 
resulting in tissue injury and damage. 
 
 Puncture Wounds: 
They are caused by some object puncturing the skin, such as needle or 
nail. Chances of injection in them are common because dirt can enter into the 
depth of wound. 
 
 Gunshot Wounds: 
They are caused by a bullet or similar driving into or through the body. 
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 Penetration Wounds: 
Penetration wounds are caused by an object such as a knife entering and 
coming out from the skin. 
 
(b) Closed Wound: 
In closed wounds blood escapes the circulating system but remain in the body. It 
includes contusion or bruises, heamatomas or blood tumor, Crush injury etc. 
 
 Contusions or bruises: 
Bruises are caused by a blunt force trauma that damage tissue under the 
skin. 
 
 Hematomas or blood tumor: 
They are caused by damage to a blood vessel that consequently causes 
blood to collect under the skin. 
 
 Crush injury: 
Crush injury is caused when great or extreme amount of force is applied 
on the skin over long period of time. 
 
 Acute Wounds: 
Acute wound is a tissue injury that normally proceeds through an orderly 
and timely reparative process that results in sustained restoration of anatomic and 
functional integrity. Acute wounds are usually caused by cuts or surgical incisions 
and complete the wound healing process within the expected time frame. 
 
 Chronic Wounds: 
Chronic wounds are wounds that have failed to progress through the 
normal stages of healing and therefore enter a state of pathologic inflammation 
chronic wounds either require a prolonged time to heal or recur frequently. Local 
infection, hypoxia,   trauma, foreign bodies and systemic problems such as 
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diabetes mellitus, Malnutrition, immunodeficiency or medications are the most 
frequent causes of chronic wound. 
 
 FACTOR AFFECTING WOUND HEALING8: 
 Improper diet 
 Infection at the wound site 
 Insufficient oxygen supply and tissue perfusion to the wound area 
 Drugs 
 Elderly age 
 Diabetes and other diseases conditions 
 
Wound healing is normal biological process in the human body. Many factors can 
adversely affect this process and lead to improper and impaired wound healing. 
 
Improper Diet: 
Wound healing is anabolic process that requires both energy and nutritive 
substrates. It is reported that serum albumin level of 3.5gm/dl or more is necessary for 
proper wound healing. Protein is essential for collagen synthesis on wound site. A state 
malnutrition may provide an inadequate amount of protein and this can decreased the rate 
of collagen synthesis wound tensile strength or increased chance of infection 
  
Infection at the Wound Site: 
Wound infection is probably the most common reason of impaired wound 
healing. Streptococcus aeureus, Streptococcus pyrogens, Escherichia coli and 
Pseudomonas aeruginosa. 
 
Insufficient Oxygen Supply and Tissue Perfusion to the Wound Area: 
Adequate blood supply and tissue perfusion is extremely important for wound 
healing. Excessive pain, cold and anxiety can cause local vasoconstriction and increased 
healing time. Smoking and use of tobacco decreased tissue perfusion and oxygen tension 
in wound. 
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Drugs: 
Many drugs are known to impair wound healing. Chemotherapeutic drugs are 
used in cancer are the largest group well known to delay wound repair. Systemic 
glucocorticoids interfere normal healing process by reducing collagen synthesis and 
fibroblast proliferation. 
 
Elderly Age: 
Elderly age is found to be associated with delay wound healing. It is reported that 
the fibroblast growth and activity diminishes and collagen production, wound contraction 
is slow in older individuals 
 
Diabetes and Other Diseases: 
Diabetic patients are more susceptible to wound healing. In study wound infection 
rate was found 11% higher in diabetic patients than in general patient’s population. Acute 
and chronic liver diseases also associated with delay wound healing. Patients with altered 
immune faction have an increased susceptibility to wound infection. 
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PHASES INVOLVED IN WOUND HEALING: 
                                                        Wounding 
                                                               Calendulus succus – topical antimicrobial      
                                                       Hemostasis   
                                                    Inflammatory Phase 
                                                                Vitamin A- enhances early inflammatory phase              
                                                                Brometalin – prevent prolonging inflammatory phase 
                                                                Vitamin C –enhances neutrophil migration 
                                                   Proliferative phase  
                                                               VitaminC-necessary for collagen synthesis 
                                                               Centilla asiatica-promotes type- 1 collagen synthesis 
                                                               Glucosamine – enhances hyaluronic acid production 
                                                               VitaminA – promotes epithelial cell differentiation. 
                                                               Zinc – required for DNA synthesis,cell division. 
                                                               Calendula succus and aloevera: support granulation 
                                    Remodelling (Protein deficiency) – inhibits wound remodeling    
THE INFLAMMATORY PHASE9: 
The inflammatory phase starts immediately after the injury that usually last 
between 24 and 48 hrs and may persist for up to 2 weeks in some cases the inflammatory 
phase launches the haemostatic mechanisms to immediately stop blood loss from the 
wound site. Clinically recognizable cardinal sign of inflammation, rubor, calor, tumor, 
dolor and function-laesa appear as the consequence. This phase is characterized by 
vasoconstriction and platelet aggregation to induce blood clotting and subsequently 
vasodilatation and phagocytosis to produce inflammation at the wound site. 
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FIBROBLASTIC PHASE10: 
The second phase of wound healing is the fibroblastic phase that lasts upto 2 days 
to 3 weeks after the inflammatory phase. This phase comprises of three steps viz. 
granulation, contraction and epithelialisation. In the granulation step fibroblasts form a 
bed of collagen and new capillaries are produced. Fibroblast produces a variety of 
substances essential for wound repair including glycosaminoglycans and collagen. Under 
the step of contraction wound edges pull together to reduces the defects in the third step 
epithelial tissues are formed over the wound site. 
 
EPITHELIZATION PHASE11: 
Epithelial cell migration is one of the vital processes of wound healing. The stem 
cells of epithelium must detach from the edges of the wound and migrate into wound. 
Normally dermal basal cells adhere to each other and to the underline basal layer of the 
dermis. Following mobilization, epithelial cells begin to enlarge and migrate down and 
across the wound. Transected hair follicles also contribute to the number of migrating 
epithelial cells. Epithelial cell migrating across wound usually move along the basal 
lamina or fibrin deposits, this phenomenon is called contact guidance and is an important 
factor in epithelial migration. Epithelial migration is followed by increased mytosis of 
epithelium. Recent evidence suggests that a water soluble heat labile substance called 
chalcone which is secreted at the wound site is responsible for regulation for mytosis. 
 
PROLIFERATIVE PHASE12: 
Proliferative Phase (2 days to 3 weeks) includes: 
 Granulation stage: Fibroblasts lay bed of collagen fills defect and 
produces new 
 Contraction stage: Wound edges pull together to reduce defect 
 Epithelialization stage: Crosses moist surface cell travel about 3 
cm from point of origin in all directions 
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CONTRACTION PHASE13: 
Wound contraction is caused by the action of differentiated fibroblasts 
(myofibroblasts) in the granulation tissue, which contain filaments of smooth muscle 
actin. Contraction of these fibroblasts makes the wound margins move toward the center 
of the wound. Wound contraction started sooner in ponies than in horses and it was 
significantly more pronounced in ponies. Additionally, it was significantly more 
pronounced in body wounds compared with the limb wounds. As a result, second 
intention wound healing was significantly faster in ponies than in horses, and 
significantly faster in body wounds than in metatarsal wounds. Histology showed that 
myofi-broblasts were more organized in the wounds of the ponies: the myofibroblasts in 
the newly formed granulation tissue were transformed into a regularly organized pattern 
within 2 weeks, in which the cells were orientated perpendicular to the vessels and 
parallel to the wound surface. This appears to be a more favorable condition for wound 
contraction to occur. In the horses, myofibroblast organization took much longer. No 
differences were found in the number of fibroblasts, the amounts of smooth muscle actin 
and collagen. Further research was performed to investigate whether the differences in 
wound contraction between horses and ponies were caused by differences in the inherent 
contraction capacity of fibroblasts or the local environment of the fibroblasts. It was 
found that no differences existed in the inherent contraction capacity of fibroblasts from 
ponies and horses in vitro. However, the level of Transforming Growth Factor,the most 
important instigator of wound contraction, was significantly higher in the granulation 
tissue of pony wounds compared with horse wounds. 
 
REMODELING PHASE14: 
This phase last for 3 weeks to 2 years. New collagen is formed in this phase. 
Tissue tensile strength is increased due to intermolecular cross-linking of collagen via 
vitamin-C dependent hydroxylation. The scar flattens and scar tissues become 80% as 
strong as the original. 
 
The wound healing activities of plants have since been explored in folklore. Many 
ayurvedic herbal plants have a very important role in the process of wound healing. 
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Plants are more potent healers because they promote the repair mechanisms in the natural 
way. Extensive research has been carried out in the area of wound healing management 
through medicinal plants. Herbal medicines in wound management involve disinfection, 
debridement and providing a moist environment to encourage the establishment of the 
suitable environment for natural healing process. 
 
ACTIVITIES LEADING TO WOUND HEALING: 
(a) Anti-inflammatory Activity: 
The acute inflammatory response during the early stages of injury generates 
factors that are essential for tissue growth and repair. When prolonged, however, chronic 
inflammation can be detrimental, preventing wound remodeling and matrix synthesis, 
leading to delay in wound closure and an increase in wound pain. Thus, it is possible that 
an anti-inflammatory effect could facilitate wound healing and improve patient comfort, 
although traditional texts and animal studies indicate that extracts exert an anti-
inflammatory effect. 
(b) Antioxidant Effect: 
The production of free radicals at or around the wound bed may contribute to 
delay in wound healing through the destruction of lipids, proteins, collagen, proteoglycan 
and hyaluronic acid. Agents that demonstrate a significant antioxidant activity may, 
therefore, preserve viable tissue and facilitate wound healing. 
(c) Antimicrobial Activity: 
Wound healing can also be delayed when micro organisms are present in large 
enough numbers. Therefore, reducing the bacterial load of a wound may be necessary to 
facilitate wound healing as well as to reduce local inflammation and tissue destruction. 
An ideal agent for the prevention and control of wound infection would therefore be one 
that directly destroys the pathogens while also stimulate immune activity. 
(d) Analgesic Activity: 
The open wounds can generate pain and subsequent disability, it is important that 
the dressing applied does not increase pain, and, if possible, it should lessen the pain. 
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REVIEW OF LITERATURE 
Pulok K .Mukherjee et al 15 studied the in-vivo wound healing activity of leaf 
extract of Hypericum mysorense with different wound model in rats. The methanol 
extract of leaves of Hypericum mysorense, in the form of ointment in two different 
concentrations (5% and 10% w/w ointment of aerial part extract in simple ointment base) 
was evaluated for wound healing potential in excision wound model and incision wound 
model in rats. Both the concentrations of the methanol extract ointment showed 
significant responses in both the wound types tested when compared with the control 
group. The effect produced by the extract ointment, in terms of wound contracting ability, 
wound closure time, regeneration of tissues at wound site, tensile strength of the wound 
and histopathological characteristics were comparable to those of a standard drug 
Nitrofurazone ointment. 
Shilpashree H.P et al 16studied the in vitro plant regeneration and accumulation 
of flavonoids in Hypericum mysorense, which could be used for large scale production in 
pharmaceuticals. 
A.A. Leslie Gunatilaka,  et al17 isolated and characterized simple xanthones from 
the phenolic fraction of the chloroform extract of the timber of Hypericum mysorense. 
The presence of simple xanthones in this genus supports the classification 
of Hypericum in the subfamily Hypericoideae in Guttiferae. 
Shanmugam Moorthi et al18 studied the effect of ethanolic extract of the 
Hypericum mysorense on antioxidant and antidepressant activity in the liver and brain of 
reserpine induced rats.  Oral administration of ethanolic extract of Hypericum mysorense 
(0.12g/kg) for 30 days to reserpine induced rats caused a significant increase in 
superoxide dismutase, catalase, glutathione peroxidase, glutathione – S – transferase, 
glutathione reductase, glucose 6 phosphate dehydro-genase, glutathione, vitamin C, 
vitamin E, total sulfhydryl group, non protein sulfhydryl group in liver and brain of 
reserpine induced rats.   The results indicate the antioxidant and antidepressant effect of 
ethanolic extract of Hypericum mysorense. 
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P. Vijayan, C. Raghu et al19screened various plant extracts for antiviral 
properties by cytopathic effect inhibition assay and virus yield reduction assay and 
determined that Hypericum mysorense exhibited significant antiviral activity at a 
concentration non toxic to the cell line used. 
Atul Murlidhar Wahile 20investigated the analgesic potential of ethyl acetate and 
methanolic extracts of Hypericum mysorense through hot plate method and acetic acid 
induced writhing test in mice. 
H. Raghu Chandrasekhar et al21 carried out a study on methanolic extracts of 
different parts of Hyperium mysorense namely aerial parts, flowering tops, leaf, root and 
stem for its in vitro and in vivo anti cancer activities. 
Atul Murlidhar Wahile20 , proved that in carrageenan-induced rat paw edema 
model, ethyl acetate extract of Hypericum mysorense showed significant (P<0.05) anti-
inflammatory activity by inhibiting inflammation. 
S. Gopinath et al22 carried out to determine the possible bioactive components of 
leaf and bark of Hypericum mysorense using GC-MS. 
A. K Singhal et al 23evaluated the wound healing property of ethanolic extract of 
Argyreia nervosa in normal and diabetic animals by oral and topical administration and 
demonstrated that A. nervosa leaves extract applied topically promotes healing of wounds 
more significantly as compared to oral application, in both normal rats and alloxan 
induced diabetic rats, where healing is otherwise delayed 
A. Jaswanth et al 24studied the wound healing effect of methanolic extract of the 
root of Aegle marmelos by formulating it in the form of an ointment with two different 
concentrations (5% and 10% w/w in simple ointment base) in excision wound model and 
incision wound model in rats. In both the concentrations, the extract ointment produced a 
significant response in both the wound types tested, as evidenced by its wound 
contracting ability, wound closure time and increase in the tensile strength. The results 
were also comparable to those of a standard drug nitrofurazone. 
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Mohammad Zuber et al25 isolated the bulbs of Allium sativum(Family:Liliaceae) 
and screened for wound-healing activity on the Swiss albino rats by excision  wound 
model and incision wound model respectively. The studies on excision wound model 
reveals significant wound healing activity of the extract, which is comparable with the 
reference control framycetin.  
Ahmad Oryan et al26 evaluated the wound healing properties of Aloe vera (Aloe 
barbadensis) on cutaneous wounds. The lesions of the treated animals showed a better 
alignment, fewer inﬂammatory cells inﬁltration and signiﬁcantly improved  
biomechanical properties on day 20 (P<0.05). These results suggested that application of 
Aloe vera aqueous extract on open wounds induces signiﬁcant wound contraction and 
accelerates healing. 
C C Barua et al27, worked on wound healing activity of methanolic extract of 
leaves of Alternanthera brasiliana Kuntz using in vivo and in vitro models and proved to 
have significant effect. 
Nayak B S et al 28 ,study aimed to evaluate the wound-healing activity of fruit 
extract of Persea americana (avocado) in rats .The extract-treated wounds were found to 
epithelialise faster than the controls (p < 0.001). 
C C Barua et al29, study was aimed to evaluate the wound healing activity of the 
methanol extracts of leaves of Azadirachta indica (neem) and Tinospora cordifolia 
(guduchi)  using excision and incision wound models in Sprague Dawley rats. The study 
thus revealed promising wound healing activity of methanolic extract of A. indica and T. 
cordifolia and provides a scientific rationale for the traditional use of these plants in the 
management of wounds.  
A Osunwoke Emeka et al30, investigated The wound healing effect of the 
aqueous leaves extracts of Azadirachta indica on adult male wistar rats. The extracts of 
Azadirachta indica significantly increased (p<0.05) the day of complete wound closure in 
experimental group compared to control group. Aqueous leave extracts of Azadirachta 
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indica promotes wound healing activity through increased inflammatory response and 
neovascularization. 
S.K. Purohit et al31, undertook an evaluation on Azadirachta indica (Neem) 
leaves ethanolic extract for wound healing activity through topical route on excision 
wound model. The activity was compared with standard drug Povidone Iodine ointment 
(5% w/w). Azadirachta indica leaves ethanolic extract was found to have better and faster 
wound healing effect than standard drug Povidone Iodine ointment on excision wound 
model.  
S. Murthy et al 32, carried out evaluation of in vivo wound healing activity of 
Bacopa monniera on different wound model in rats. It decreased myeloperoxidase and 
free radical generated tissue damage, promoting antioxidant status, faster collagen 
deposition, other connective tissue constituent formation, and antibacterial activity. 
M. Saroja et al33, carried out a study on the wound healing activity of flavonoid 
fraction of Cynodon dactylon in Swiss albino rat. The study revealed that the wound 
healing activity may be due to free radical scavenging activity of flavonoid fraction. 
Shivananda Nayak et al34, evaluated the wound healing activity of Allamanda 
cathartica. L. and Laurus nobilis. L. extracts on rats. The data of this study indicated that 
the leaf extract of Allamanda possesses better wound healing activity than the Laurus 
nobilis and it can be used to treat different types of wounds in human beings too. 
Renu Solanki et al35, carried out a study on ethanolic extract of leaves of Aegle 
marmelos and Ocimum basilicum for its wound healing activity through topical route on 
excision wound model. The activity was compared with standard drug povidone iodine 
ointment (5% w/w) respectively. The leaves ofAegle marmelos ethanolic extract was 
found to have better wound healing effect than ethanolic extract of leaves of Ocimum 
basilicum on excision wound model. The leaves of Aegle marmelos ethanolic extract also 
showed faster rate of healing when compared with standard topical application. 
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Vipin Kumar Garg et al36, The wound-healing efficacy of ethanolic and aqueous 
extracts of Ficus benghalensis was evaluated in excision and incision wound models. The 
parameters studied include rate of wound contraction, period of complete 
epithelialization, and tensile strength of incision wound. Student's t test was used to 
analyze the results obtained from the present study and P<0.05 was considered 
significant. Both the ethanolic and aqueous extracts of F. benghalensis were found to 
possess significant wound-healing activity. 
B Shivananda Nayak et al37 , worked on the aqueous extract of Carica papaya 
fruit for its wound healing activity in streptozotocin- induced diabetic rats using excision 
and dead space wound model. The extract treated wounds epithelize faster than control. 
S Ambiga et al38, isolated the flowers of Ipomoea carnea(Family: 
Convolvulaceae) , and was screened for wound-healing activity on the male wistar rats by 
excision wound model and incision wound model respectively. The studies on excision 
wound model reveals significant wound healing activity of the extract, which is 
comparable with the reference control sulphathiazole. 
Kokane DD et al 39 , studied on the roots of Mimosa pudica for wound healing 
activity by incorporating the methanolic and the total aqueous extract in simple ointment 
base B.P in concentration of 0.5% (w/w), 1% (w/w) and 2% (w/w) using  three types of 
model in rats viz. excision, incision and estimation of biochemical parameter. The 
methanolic extract exhibited good wound healing activity probably due to phenols 
constituents. 
Mahmood A. Abdulla et al 40, assessed the effects of topical application 
of Rafflesia hasseltii buds and flowers extract on the rate of wound healing and histology 
of healed wound , the findings of increased rate of wound closure and contraction 
together with the histological findings suggest that Rafflesia hasseltii buds extract is very 
effective in accelerating the wound healing process. 
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Kotade Kiran et al 41, studied on the wound healing activity of Sesamum indicum 
L seed and oil in rats using Aloe vera as standard healing agent and the result suggested 
excellent wound healing property. 
Agren M S et al 42, investigated the effect of topically applied zinc on leg ulcer 
healing and examined its effect on some mechanisms in wound healing using 
standardized animal models. 
K N Chidambara Murthy et al 43,carried out a study on the methanolic extract 
of dried pomegranate (Punica granatum) peels by formulating it  as a 10% (W/W) water-
soluble gel for its wound healing property against an excision wound on the skin of 
Wistar rats. The activity was compared with that of a commercial topical antibacterial 
applicant. The wound healing activity was assessed by measuring the percent contraction 
in skin and estimation of collagen content in terms of hydroxyproline content. 
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AIM AND OBJECTIVE 
Aim: 
The present studies aim is to highlight the use of Hypericum mysorense for the 
treatment of cuts and wounds as a wound healer. The study involves the formulation and 
evaluation of methanolic extract of Hypericum mysorense as a semi-solid dosage form for 
its wound healing activity. 
 
Objective: 
 To carry out continous hot percolation of Hypericum mysorense using methanol 
as solvent. 
 To evaluate phytochemical constituents of the obtained methanolic extract of 
Hypericum mysorense. 
 To evaluate the methanolic extract of Hypericum mysorense for its in-vitro 
antioxidant and antimicrobial property. 
 To formulate methanolic extract of Hypericum mysorense as a semi-solid dosage 
form (ointment). 
 To evaluate the physiochemical parameters of the formulated ointment. 
 To conduct HPTLC analysis, in-vitro diffusion studies, release kinetics and 
stability studies of the prepared ointment. 
 To assess the wound healing property of the prepared herbal ointment by excision 
wound model. 
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PLAN OF WORK 
1. Extraction of Hypericum mysorense by continous hot percolation using methanol 
as solvent. 
2.  Phytochemical analysis of the methanolic plant extract. 
3. Assessment of the in-vitro antimicrobial screening by disc diffusion method. 
a) Anti- bacterial Screening 
b) Anti-fungal Screening 
4. Evaluation of in-vitro antioxidant property of the methanolic extract. 
a) DPPH Assay 
b) FRAP Assay 
     5.  Formulation of methanolic extract of Hypericum mysorense as a semi-solid 
dosage   form (ointment). 
6. Evaluation of the physiochemical parameters of the formulated ointment. 
a) Colour and odour 
b) Loss on drying 
c) pH 
d) Spreadability 
e) Extrudability 
f) Stability Study 
 
7. Carry out the HPTLC analysis diffusion studies release kinetics and stability 
studies of  the prepared semi-solid dosage form. 
 
8. Assessment of wound healing property of the prepared herbal ointment by 
excision wound model. 
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PLANT PROFILE44,45 
 COLLECTION AND AUTHENTICATION: 
          The plant Hypericum mysorense was collected in and around Ooty. The 
taxonomical identification of plant was authenticated by Dr. S. Rajeswari, Department of 
Botany, PSG College of Arts and Science, Coimbatore.  
                               
DESCRIPTION OF PLANT’S BOTANICAL INFORMATION:  
                        Botanical name          : Hypericum mysorense                                  
                        Family                        :  Hypericaceae 
CLASSIFICATION: 
                          Kingdom                :  Plantae 
                         Sub Kingdom         :  Tracheobionta 
                         Super division        :  Spermatophyta 
                         Division                  :  Magnoliophyta 
                         Class                       :  Magnoliopsida 
                         Subclass                  :  Dilleniidae 
                         Order                       :  Malpighiales 
                         Family                     :  Hypericaceae 
Plant Profile  
Dept of Pharmaceutics, KMCH College of Pharmacy Page 28 
 
                         Subfamily                : Hypericoideae 
                         Tribe                        : Hypericeae 
                         Genus                      :  Hypericum 
                         Species                    : mysorense 
                         Habit                        : Shrub 
MORPHOLOGY: 
Leaves are simple alternate stipulate petiolate. Leaves with petiole 1-4 mm; blade 
narrowly lanceolate to oblong-lanceolate or broadly ovate, (1.7-)2.5-7.8 × (0.7-)1-3.2 cm, 
abaxially paler or ± glaucous; laminar glands short streaks to dots; abaxial glands dense 
to sparse or absent; main lateral veins (2 or)3- or 4-paired, without visible tertiary 
reticulation; base narrowly cordate to subcordate, apex acute to rounded. Inflorescence 1-
5-flowered, from apical node, nearly round-topped; bracts deciduous, lanceolate or 
narrowly oblong to obovate-spatulate. Pedicels 3-16 mm.  
The bark is externally brownish and internally light reddish brown in color. It 
occurs in the curved or sometimes flat pieces with size of 7-8 × 18-20 cm and thickness 
about 1.5-3 cm. It has mucilaginous taste which is followed by bitter sensation. The odor 
is characteristic, unpleasant and has slight astringent effect on throat. The bark shows 
fibrous fracture. 
The bark shows number of masses of moss and fungal growth. The outer surface 
of bark has got numerous lenticels. Number of ringles and undulations are also seen on 
the outer surface, while inner surface shows presence of numerous striations. The bark is 
smooth and has glistering appearance due to the numerous shinning calcium oxalate 
crystals in sunlight. Overall the bark is compact, hard and lighter in weight. Fresh bark 
detached from the trunk of the tree is yellowish a turns to brown and then reddish brown 
on storage. 
 
MEDICINAL USES:  
 
 It is an ornamental plant having antibacterial activity, active against both gram-
positive and gram-negative bacteria. 
 Leaf and flower have strong antioxidant potential and used for liver disorders. 
 Its stem is having strong antitumor, antipsychic and antiviral activities.  
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METHODOLOGY 
A. COLLECTION AND EXTRACTION45 
The leaves of Hypericum mysorense was collected freshly during the month of 
October from Ooty, India, identified and authenticated by Dr. S Rajeswari,Department of 
Botany, PSG College of Arts and Science, Coimbatore comparing with the voucher 
specimen present in the herbarium. The collected plant, Hypericum mysorense was 
extracted by continuous hot percolation (soxhletation). 200g of powdered stem of 
Hypericum mysorense was defatted using petroleum ether. The marc obtained from the 
powdered plant part was successfully extracted with 250 ml of methanol by using soxhlet 
apparatus. The extraction was carried out for 48 hours. After extraction, the solvents were 
distilled out; the concentrated residues were analyzed by chemical tests. 
 
B. EVALUATION OF METHANOLIC EXTRACT OF Hypericum mysorense 
(MeOH HMS): 
The extract was evaluated for the following parameters: 
 Phytochemical Analysis 
 Invitro Antimicrobial Studies  
 Invitro Antioxidant Property 
I. PHYTOCHEMICAL ANALYSIS46-51  
 The phytochemical screening of MeOH HMS for various phytoconstituents like 
carbohydrate, proteins, amino acids, flavonoids, glycosides, saponins, alkaloids, steroids 
and tannins were done. 
1. Test for carbohydrates: 
a. Molisch’s test 
 To 2-3ml of aqueous extract, added few drops of alpha naphthol solution in 
alcohol. Shaken and then added concentrated sulphuric acid from sides of test tube. A 
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brown purple ring   formed at the junction of the two liquids indicates the presence of 
sugars. 
b. Fehling’s test 
  Mixed 1ml Fehling’s solution A and 1ml of Fehling’s solution B and boiled for 1 
minute, added equal volume of test solution and heated on boiling water bath for 5-10 
mins. Formation of brick red precipitate confirms the presence of sugars. 
c. Benedict’s test 
  Mixed equal volume of Benedict’s reagent and test solution in a test tube, heated 
in boiling water bath for 5 mins. Formation of brick red precipitate confirms the presence 
of sugars. 
d. Barfoed’s test 
  Mixed equal volume of Barfoed’s reagent and test solution. Heated for 1-2 mins 
in boiling water bath and cooled. An orange red precipitate confirms the presence of 
sugars. 
2. Test for glycosides: 
 Heated on a water bath and the hydrolysate was subjected to Legal, Keller 
Killiani, Borntrager’s and modified Borntrager’s test to detect the presence of 
glycosides. 
 
a. Legal test 
 To the hydrolysate, 1ml of pyridine and few drops of sodium nitroprusside 
solution were added and then it was made alkaline with sodium hydroxide solution. A 
blood red colour indicates the presence of glycosides. 
 
b. Borntrager’s test 
 The hydrolysate was treated with chloroform and the chloroform layer was 
separated. To this, equal quantity of dilute ammonia solution was added. A light pink 
colour at the interface between two liquids indicates the presence of glycosides 
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3. Test for alkaloids: 
a. Mayer’s test 
 Methanolic extract was treated with drops of hydrochloric acid and filtered. The 
filtrate was treated with Mayer’s reagent. Yellowish buff colour indicates the 
presence of alkaloids. 
 
b. Dragendroff’s test 
 Methanolic extract was treated with few drops of Dragendroff’s reagent. Orange 
red precipitate indicates the presence of alkaloids. 
 
c. Wagner’s test 
 Methanolic extract was treated with drops of hydrochloric acid and filtered. The 
filtrate was treated with Wagner’s reagent. Reddish brown precipitate indicates the 
presence of alkaloids. 
 
d. Hager’s test 
 Methanolic extract was treated with drops of hydrochloric acid and filtered. The 
filtrate was treated with Hager’s reagent. Reddish brown colour indicates the presence 
of alkaloids. 
 
4. Test for flavonoids 
a. A small quantity of solvent free methanolic extract was dissolved in alcohol 
separately and it was hydrolyzed with 10% sulphuric acid and cooled. Then it was 
extracted with diethyl ether and divided in to three portions in two separate test tubes 
for each extract. 1ml of dilute sodium carbonate, l ml of 0.1M sodium hydroxide and 
1ml of diluted ammonia solution were added to the first and second test tubes 
respectively. In each test tube, development of yellow colour demonstrated the 
presence of flavonoids. 
b. Ferric chloride test: 
  To a small quantity of the alcohol solution of extract few drops of neutral ferric 
chloride solution were added. Formation of blackish red colour demonstrated the 
presence of flavonoids. 
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c. Shinoda’s test 
 To the alcoholic solution of extract a small piece of magnesium ribbon and few 
drops of concentrated hydrochloric acid were added and heated, a magenta colour  
indicates the presence of flavonoids in methanol extract. 
 
5. Test for proteins: 
a. Biuret test 
   The extract was treated with equal volume of 40% sodium hydroxide and 2 drops 
of 1% copper sulphate solution. Pink or purple colour indicates the presence of 
proteins.  
b. Millon’s test 
 To the extract, few drops of Millon’s reagent was added and heated. Appearance 
of red colour indicates the presence of proteins and free amino acids. 
 
c. Ninhydrin test 
  A small quantity of extract solution was boiled with 0.2% solution of Ninhydrin. 
Blue colour indicates the presence of free amino acids. 
 
6. Test for tannins: 
 Small quantity of the extract was dissolved in distilled water, filtered and tested 
for the presence of phenolic compounds and tannins using the following reagents: 
a. With dilute ferric chloride solution (5%) - development of greenish black coloration 
indicates the presence of tannins. 
b.  With 10% lead acetate solution - development of yellow colour precipitate indicates 
the presence of tannins.  
c. With 10% aqueous potassium dichromate solution - development of yellowish brown 
precipitate indicates the presence of tannins.  
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7. Test for saponins: 
a. Foam test 
 To the extract, 20ml of distilled water was added and agitated in a graduated 
cylinder for 15 mins. The formation of about 1cm layer of foam indicates the 
presence of saponins. 
 
8. Test for steroids and triterpenoids: 
a. Libermann-Burchard reaction 
Small quantities of solvent free methanol extract were separately dissolved in l ml 
of chloroform and lml of acetic anhydride was then added followed by 2ml of 
concentrated sulphuric acid. A reddish violet ring at the junction of the two layers 
indicates the presence of triterpenoids and steroids. 
 
b. Salkowski's test 
Concentrated sulphuric acid was added to a chloroform solution of the extracts 
(l0mg of extract in lml of chloroform),a reddish blue colour in the chloroform layer 
and green fluorescence in acid layer, suggests the presence of steroids. 
II. INVITRO- ANTIMICROBIAL STUDIES 52-53 
  Antimicrobial testing is done for any organism that contributes to an infectious 
disease warranting antimicrobial therapy. These studies are done by two methods: 
 Zone of inhibition (disc diffusion method) 
DISC DIFFUSION METHOD 
PRINCIPLE: 
  When a filter paper disc impregnated with a chemical is placed in medium 
containing agar, the chemical will diffuse from the disc into the agar. The diffusion 
places the chemical in the agar around the disc. The area of chemical infiltration around 
the disc is determined by the solubility of the chemical and its molecular size. An 
organism placed on the agar fails to grow in the area around the disc if it is susceptible to 
 Methodology  
 
Dept of Pharmaceutics, KMCH College of Pharmacy Page 34 
 
the chemical. This area around the disc where no growth is observed is known as a “zone 
of inhibition”. 
  The drug potency is established by comparing the inhibition produced by the test 
compound with that produced by known concentration of reference standard. When 
performing these tests certain things are held constant so only the size of the zone of 
inhibition is variable. Conditions that must be constant from test to test include the agar 
used, the amount of organism used, the concentration of chemical used, and incubation 
conditions (time, temperature and atmosphere). 
A. ANTI BACTERIAL SCREENING BY DISC DIFFUSION METHOD  
PREPARATION OF INOCULUM 
  The inoculums for the experiment were prepared in fresh Nutrient broth from 
preserved slant culture. The inoculums were standardized by adjusting the turbidity of the 
culture to that of McFarland standards. The turbidity of the culture may be adjusted by 
the addition of sterile saline or broth  
PREPARATION OF STERILE SWABS 
  Cotton wool swab on wooden applicator or plastics were prepared and sterilized 
by autoclaving or dry heat (only for wooden swabs) by packing the swabs in culture 
tubes, papers or tins etc. 
STERILIZATION OF FORCEPS 
  Sterilize forceps by dipping in alcohol and burning off the alcohol 
PROCEDURE 
  The standardized inoculums is inoculated in the plates prepared earlier 
(aseptically) by dipping a sterile in the inoculums removing the excess of inoculums by 
passing by pressing and rotating the swab firmly against the side of the culture tube 
above the level of the liquid and finally streaking the swab all over the surface of the 
medium 3 times rotating the plate through an angle of 60 ͦ C after each application. 
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Finally pass the swab round the edge of the agar surface. Leave the inoculums to dry at 
room temperature with the lid closed. 
  Each petri dish is divided into 3 parts, in 2 parts extract discs such as control and 
MeOH HMS (100mcg) discs (discs are soaked overnight in extract solution) and one 
quadrant for standard Ciprofloxacin 10mcg, are placed in each quadrant with the help of 
sterile forceps. The petri dishes are placed in the refrigerator at 4 º C or at room 
temperature for 1 hour for diffusion. Incubate at 37 º C for 24 hours. Observe the zone of 
inhibition produced by different samples. Measure it using a scale or divider or venire 
calipers and record the average of two diameters of each zone of inhibition.         
                               Table I: List of bacteria used for the study  
Sl.no Gram positive bacteria Gram negative bacteria 
    1. Bacillus subtilus Escherichia coli 
    2. Staphylococcus aureus Salmonella paratyphi  
 
B. ANTI FUNGAL SCREENING BY DISC DIFFUSION METHOD 
PREPARATION OF INOCULUM 
  The inoculums for the experiment were prepared in fresh sabouraud’s broth from 
preserved slant culture. The inoculums were standardized by adjusting the turbidity of the 
culture to that of McFarland standards. The turbidity of the culture may be adjusted by 
the addition of sterile saline or broth. 
PREPARATION OF STERILE SWABS 
  Cotton wool swab on wooden applicator or plastics were prepared and sterilized 
by autoclaving or dry heat (only for wooden swabs) by packing the swabs in culture 
tubes, papers or tins etc. 
STERILIZATION OF FORCEPS 
  Sterilize forceps by dipping in alcohol and burning off the alcohol. 
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PROCEDURE 
  The standardized inoculums is inoculated in the plates prepared earlier 
(aseptically) by dipping a sterile in the inoculums removing the excess of inoculums by 
passing by pressing and rotating the swab firmly against the side of the culture tube 
above the level of the liquid and finally streaking the swab all over the surface of the 
medium 3 times rotating the plate through an angle of 60 º after each application. Finally 
pass the swab round the edge of the agar surface. Leave the inoculums to dry at room 
temperature with the lid closed. 
  Each petri dish is divided into 3 parts , in 2 parts  extract discs such as Control 
and MeOH HMS (100mcg) discs ,(discs are soaked overnight in extract solution) and one 
quadrant for standard clotrimazole 10mcg, are placed in each quadrant with the help of 
sterile forceps. Then petri dishes are placed in the refrigerator at 4 º C or at room 
temperature for 1 hour for diffusion. Incubate at room temperature for 24 - 48 hours. 
Observe the zone of inhibition produced by different samples. Measure it using a scale or 
divider or venire calipers and record the average of two diameters of each zone of 
inhibition. 
Table II: List of fungus used for the study 
Sl.no Fungi 
1. Candida albicans 
2. Aspergillus niger 
 
III.INVITRO-ANTIOXIDANT STUDIES 54-56 
  
A. DPPH RADICAL SCAVENGING ASSAY 
 The molecule of 1, 1-diphenyl-2-picryl-hydrazyl (α, α-diphenyl-β-picryl 
hydrozyl) is characterized as a stable free radical by virtue of the delocalization of the 
spare electron over the molecule as a whole, so that the molecules do not dimerise, as 
would be the case with most other free radicals. The delocalization also gives rise to the 
deep violet color, characterized by an absorption band in ethanol/methanol solution 
centered at about 520 nm. When a solution of DPPH is mixed with that of a substance 
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that can donate a hydrogen atom, then this gives rise to the reduced form  with the loss of 
this violet color (although there would be expected to be a residual pale yellow color 
from the picryl group still present). Representing the DPPH radical by Z• and the donor 
molecule by AH, the primary reaction is Z•+ AH = ZH + A• 
 
   Radical scavenging activity of methanolic extract against stable DPPH (2, 2-
diphenyl-2-picrylhydrazyl hydrate), was determined spectrophotometrically. The changes 
in color (from deep—violet to light—yellow) were measured at 517nm on a UV/visible 
light spectrophotometer. 
                                    
                                   Radical Form                          Reduced Form                                                               
 
 0.3mM solution of DPPH in methanol was prepared and 1ml of this solution was 
added to 1ml of various concentrations of sample and the reference compound (10, 20, 
30, 40 and 50 µg/ml), were shaken vigorously and left to stand in the dark at room 
temperature for 30 min and then absorbance was measured at 517 nm. A control reaction 
was carried out without the test sample. All the tests were performed in triplicate in order 
to get the mean values. The percentage of inhibition was calculated by comparing the 
absorbance values of the control and test samples. Antiradical activity was expressed as 
inhibition percentage (I %) and calculated using the following equation: 
 
                       Inhibition percentage (I %) = (Abscontrol- Abssample/Abscontrol) X 100 
 
 The previous equation the term Abssample was substituted with (Abssample-Abs blank). 
Different sample concentrations were used in order to obtain calibration curves and to 
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calculate the EC50 values (EC50: concentration required to obtain a 50% radical 
scavenging activity).  
 
B. FERRIC REDUCING ABILITY OF PLASMA/FERRIC REDUCING 
ANTIOXIDANT POWER (FRAP)  
 The method is based on the reduction of a ferric 2, 4, 6-tripyridyl-s-triazine 
complex (Fe3+-TPTZ) to the ferrous form (Fe2+-TPTZ). 
 
Reagent preparation: 
 Reagents included 300 mmol/l acetate buffer, pH 3.6 [3.1 g C2H3NaO2.3H2O 
(sodium acetate trihydrate) and 16 ml C2H4O2 (acetic acid) per liter of buffer solution]; 
10 mmol/l TPTZ (2, 4, 6-tripyridyl-s-triazine) in 40 mmol/l HCl; 20 mmol/l FeCl3.6H2O 
(ferric chloride hexahydrate). Working FRAP reagent was prepared as required by 
mixing 25ml acetate buffer, 2.5 ml TPTZ solution, and 2.5 mlFeCl3.6H2O solution in the 
ratio 10:1:1. All reagents were prepared freshly.  
 
Samples: 
 To 900 µl of FRAP reagent add different concentrations of sample solution (10, 
20, 30, 40 and 50 µg/ml) and the final volume was made up to 1ml.  
  
 The increase in absorbance at 593 nm was measured at 4 min. FeSO4.7H2O was 
used as a standard. FRAP value was expressed as mmol/100 g on dry weight basis using 
the calibration curve of Fe2+. 
C. PREPARATION OF SEMI-SOLID FORMULATION: 
I. FORMULATION OF OINTMENT: 
 Preparation of Ointment Base(Emulsifying Ointment) 
Emulsifying wax                  - 50g 
White soft paraffin               - 20g 
Liquid paraffin                     - 30g 
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Procedure56 
  Required quantities of emulsifying wax, liquid paraffin and white soft paraffin 
were weighed and melted. To this, adequate quantity of methanolic extract of plant 
was added and stirred well until a homogeneous mass were obtained. The composition 
of the prepared herbal ointment (F1) is listed in Table III. 
Table III: Composition of Ointment 
SL.NO INGREDIENTS F1 
1 
Methanolic extract of 
Hypericum mysorense stem 
2gm 
2 Emulsifying Ointment q.s to 100gm 
 
 
D.EVALUATION OF SEMI-SOLID FORMULATION: 
 
I. EVALUATION OF OINTMENT58: 
 
PHYSIOCHEMICAL EVALUATION: 
a. Colour: 
The colour of the formulation was identified by visual examination. 
 
b. Loss on drying: 
        Loss on drying was determined by placing ointment in petridish on water bath 
and dried for 1050C 
              Percentage Loss on Drying = (Weight- Molecular Weight)/Weight × 100 
 
c. pH:                                                   
 The pH of the formulation was determined by using Digital pH meter. One 
gram of ointment was dissolved in 100 ml of distilled water and stored for two 
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hours. The measurement of pH was done in triplicate and average values were 
taken.  
d. Viscosity: 
The viscosity of the formulation was determined as such without dilution by 
Brookefield  viscometer(model LV-DV-II, Helipath-spindle typeS-96). 
 
e. Melting Point: 
 Melting Point was obtained by using melting point apparatus wherein 
required quantity of sample was filled in a capillary and placed in melting point 
apparatus and noted the temperature of melting. 
 
f. Spreadability: 
  Spreadability is a term expressed to denote the extent of area to which the 
ointments readily spreads on application to skin or affected part. A special 
apparatus has been designed by Multimer to study the spreadability of 
formulations. The spreadability was expressed in terms of times in seconds taken 
by two slides to slip off from ointment and placed in between the slides under the 
direction of certain load. Lesser the time taken for separation of two slides, result 
the better spread ability. Spreadability was calculated by using the formula. 
                                                  S = (M.L/T)    
 where,     S = Spreadability 
                      M = Weight tied to upper slide 
   L = Length of glass slides and 
  T = Time taken to separate completely from each other.   
g. Extrudability 
 A simple method was adopted for this study. The formulation was filled in the 
collapsible tubes after the ointments were set in the container. The extrudability was 
determined in terms of weight in grams required to extrude a 0.5 cm of ribbon of 
ointment in 10 second. 
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h. HPTLC Analysis: 
 HPTLC analysis was conducted in KMCH College of Pharmacy.The study was 
carried out using HPTLC plate silica gel 60F 254(10×10cm) using toluene:ethyl 
acetate:formic acid:methanol (3:6:1.6:0.4) as mobile phase. The percentage of active 
ingredient(quercetin) present in the ointment containing 2% methanolic extract was 
compared with that of standard. 
i. In-vitro drug diffusion studies59 
 In-vitro diffusion studies were performed by using franz diffusion cell with a 
receptor compartment capacity of 25 ml. The synthetic cellophane membrane was 
mounted between donor and receptor compartment of the diffusion cell. The 
formulated ointment was placed over the drug release membrane and the receptor 
compartment of the diffusion cell was filled with phosphate buffer pH 7.4. The whole 
assembly was fixed on a magnetic stirrer, and the solution in the receptor 
compartment was constantly and continuously stirred using magnetic beads at 50 
rpm. The sample of 2ml were withdrawn at time interval of 30,60,90,120,150 and 
180mins, then analyzed for spectrophotomerically at  369 nm. 
j. Release Kinetics: 
To study the release kinetics, data obtained from in vitro drug release studies were 
plotted. In various kinetic models: zero order (Equation 1) as cumulative amount of 
drug released Vs. time, first order (Equation 2) as log cumulative percentage of drug 
remaining vs. time, And Higuchi’s model (Equation 3) as cumulative percentage of 
drug released vs. squareroot of time. 
 
                                   C = K0 t    (1) 
Where,   
K0: is the zero-order rate constant expressed in units of concentration/time  
              t: is the time in hours.  
A graph of concentration vs time would yield a straight line with a slope equal to 
K0 and intercept the origin of the axis. 
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                            LogC = LogCo−kt/2:303      (2) 
Where, C0: is the initial concentration of drug,  
             K: is the first order constant, and t is the time. 
 
                                Q = Kt1/2    (3) 
  Where K: is the constant reflecting the design variables of the system  
              t: is the time in hours.  
 
Hence, drug release rate is proportional to the reciprocal of the square root of time. 
 
k. Stability Studies: 
  The stability studies were carried out in formulation at different temperature 
conditions (4,25 and 40
◦
C) for 3 months. All the evaluation parameters i.e. pH, 
viscosity, spreadability, extrudability and drug content were studied at different time 
intervals i.e. 15th,30th, 60th and 90th day 
 
E. PHARMACOLOGICAL EVALUATION OF THE FORMULATED  
     OINTMENT: 
ACUTE SKIN IRRITATION STUDY  
 The primary skin irritation test was performed on albino rats and weighing about 
150-200gm. The animals were maintained on standard animal feed and had free access to 
water ad libitum. The animals were kept under standard laboratory condition. The total 
mass was divided into four batches, each batch containing six animals. Two batches of 
each were used for control and test. Dorsal hairs at the back of the rats were clipped off 
one day prior to the commencement of the study. Animals showing normal skin texture 
were housed individually in cages with meshes to avoid contact with the bedding. 50mg 
of the each formulation of different concentrations were applied over one square 
centimeter area of intact and abraded skin to different animals. Aqueous solution of 0.8% 
formalin was applied as standard irritant. The animals were observed for seven days for 
any signs of oedema and erythema. 
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WOUND HEALING ACTIVITY60  
Animals: 
 Wister rat of male sex, weighing 150-200g were used. All animals were obtained 
from KMCH College of Pharmacy. All animals were housed for at least one week in the 
laboratory animal room prior to testing. The selected animals were housed in 
polypropylene cages in standard environmental conditions (20-25⁰c). Fed with standard 
rodent diet and water as libitum. The experiments on animals were conducted in 
accordance with the international accepted principles for laboratory animal use and the 
experimental protocols duly approved by the institutional ethical committee ,KMCH 
college of pharmacy, Coimbatore, Reg No. 685/Po/02/a/CPCSEA.Dt:21st Aug 2002, 
IAEC No: KMCRET/M.Pharm/9/2013-14 
Chemicals and drugs used: 
 Anesthetic ether 
 Povidone iodine ointment. 
EXCISION WOUND MODEL61: 
Table IV: Experimental design: 
 Wister rats weighing around 150-200g were used for this study. They were divided 
into 4 groups consisting of 6 rats each. 
Table IV: Experimental Design (Excision Wound Model) 
GROUP 
TREATMENT : DOSE AND ROUTE OF 
ADMINISTRATION 
NO OF 
ANIMALS 
1 Group treated with simple ointment base 6 
2 Control group with only wound 6 
3 
Standard group treated with povidone iodine 
ointment 
6 
4 Ointment containing 2% MeOH HMS 6 
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WOUND CREATION AND EVALUATION: 
  Four groups of animals containing six in each group were anaesthetised by open 
mask method with anaesthetic ether. The rats were depilated on the back and 
predetermined area of about 1.5cm (width) x 0.2cm (depth) was made on depilated 
ethanol-sterilized dorsal thoracic region of rats.Rats wounds were left undressed to the 
open environment. Wound were inspected and photographed.This model was used to 
monitor wound contraction and  epithelization time. The progressive changes in wound 
area were monitored planimetrically by tracing the wound margin on a graph paper every 
alternate day. The changes with healing of wound, ie the measurement of wound area on 
graph paper were expressed as unit (mm2) .wound contraction was expressed as 
percentage reduction of original wound size. 
WOUND CONTRACTION ASSESSMENT BY PLANIMETRY: 
Procedure: 
  The contour of the individual wounds of both control and experimental animals 
was periodically measured using transparent graph sheet and the rate of healing was 
calculated and expressed as percentage contraction .The following formula was used to 
calculate the percentage of wound contraction. 
                 Wound contraction %= wound area day 0-wound area day n ×100 
                                                              Wound area day 0 
PERIOD OF HEALING  
  Falling of scab, leaving no raw wound behind, was taken as the point of complete 
epithelization and the days required for this were as period of epithelization. 
 
HISTOPATHOLOGICAL STUDY 
  The healing tissues obtained on the  3rd day and 9th day from all four groups of 
animals of the  excision wound model were processed for histological study to determine 
the pattern of lay-down for collagen. The amount of collagen was quantified using 
Vangeison stain. 
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RESULTS AND DISCUSSION 
A. EVALUATION OF Methanolic Extract of Hypericum mysorense(MeOH .HMS): 
I. PHYTOCHEMICAL ANALYSIS:  
 The collected plant, Hypericum mysorense was dried, extracted with methanol 
and was subjected to preliminary phytochemical screening. Phytochemical screening 
showed the presence of steroids, alkaloids, flavonoids, saponins and tannins in the 
methanolic extracts. 
Table V: Result of Phytochemical Evaluation 
CONSTITUENTS INFERENCE 
Carbohydrates and reducing sugars Absent 
Glycosides Absent 
Alkaloids Present 
Flavanoids Present 
Proteins Absent 
Tannins Present 
Saponins Present 
Steroids Present 
 
II. INVITRO ANTIMICROBIAL STUDIES: 
a. Antibacterial Screening by Disc Diffusion Method: 
 The methanolic extract was screened against various gram positive organisms like 
Staphylococcus aureus and Bacillus subtilis and various gram negative organisms like 
Escherichia coli and Salmonella paratyphi. The spectrum activity of the extract was 
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compared with ciprofloxacin as standard. From the table VI and figure 3, 4 and 5 it is 
clear that the extract possess antibacterial against selected microbial species such as 
Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Salmonella paratyphi 
which is comparable with that of the standard, Ciprofloxacin. 
Figure 3: Zone of inhibition against Gram positive bacteria 
                          
                           Bacillus subtilis                                     Staphylococcus aureus 
Figure 4: Zone of inhibition against Gram negative bacteria 
                          
                          Salmonella paratyphi                            Escherichia coli 
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The observations are tabulated in table VI                           
Table VI: Antibacterial Screening by Disc Diffusion Method 
Extract Used 
Diameter of 
Zone of inhibition 
(mm) 
Gram +ve Bacteria Gram  -ve Bacteria 
B.subtilis S.aureus E. coli S.paratyphi 
Ciprofloxacin 31 29 26 13 
MeOH.HMS 15 14 12 10 
Control 8 7 9 8 
         
MeOH .HMS- Methanolic Extract of Hypericum  mysorense stem 
Figure 5: Graphical Representation of Antibacterial Activity of Methanolic Extract 
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b. Antifungal Screening by Disc Diffusion Method: 
  The methanolic extract was screened against various fungus like Candida 
albicans and Aspergillus niger. The spectrum activity of the extract was compared with 
ciprofloxacin as standard. From the table VII and figure 6 and 7 it is clear that the extract  
possess antifungal against selected microbial species such as Candida albicans and 
Aspergillus niger which is comparable with that of the standard, Clotrimazole. 
Figure 6: Zone of inhibition against various fungus 
                                  
                        Aspergillus niger                                            Candida albicans 
The observations are tabulated in Table VII 
Table VII: Antifungal Screening by Disc Diffusion Method 
Extract Used Diameter of  Zone of 
 
Inhibition (mm) 
 Candida albicans Aspergillus niger 
Clotrimazole 30 32 
MeOH. HMS 15 16 
Control 7 7 
             MeOH .HMS- Methanolic Extract of Hypericum  mysorense stem        
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 Figure 7: Graphical Representation of Antifungal Activity of Methanolic Extract 
  
III. INVITRO ANTIOXIDANT STUDIES: 
    In-vitro anti oxidant activity was carried out by using the extract against DPPH 
and FRAP assay where ascorbic acid used as standard. The results showed that the 
extract possess anti oxidant activity. 
 
 The DPPH radicals absorb at 520 nm and this absorption is inhibited in the 
presence of antioxidants. This reduction in absorbance is related to the antiradical 
efficiency of the extract. The DPPH antiradical efficiency values of the extract analyzed 
in this study are presented in the Table VIII and figure 8. 
  The effect of methanolic extract on Fe3+ - Fe2+ transformation investigated, the 
reducing capacity of extract, may serve as a significant indicator of its potential 
antioxidant activity. Table IX and figure 9 shows the reductive effect of extract. 
 The antioxidant property of these studies may also be due to presence of phenol 
and flavonoid in our plant extract. 
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Table VIII: DPPH Assay 
 
    
 
 
 
 
 
 
                     Data is expressed as Mean ± SEM 
                                                                      Figure 8-DPPH Assay 
         
 
 
 
 
 
 
 
 
 
         
 
 
 
  CONC(µg/ml) 
% INHIBITION 
MeOH. HMS ASCORBIC 
ACID 
5 43.22±0.15 49.76±0.16 
10 53.07±0.17 53.08±0.17 
15 65.77±0.16 69.47±0.18 
20 78.33±0.15 88.42±0.14 
                    25 95.33±0.13 98.75±0.13 
EC 50 9.4±0.13 9.4±0.15 
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                                                                           Table IX: FRAP assay 
 
CONC.  
(µg/ml) 
ABSORBANCE 
 MeOH .HMS ASCORBIC ACID 
20 0.8287 1.2788 
40 1.3264 1.5477 
60 1.7279 1.8804 
80 2.0407 2.1987 
100 2.195 2.4273 
 
 
Figure 9-FRAP Assay 
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C. PREPARATION OF SEMI-SOLID FORMULATION: 
   The extract was formulated as an ointment with 2%w/w of the methanolic extract 
using simple ointment base .The formulated ointment was then subjected to various 
evaluation studies. 
D. EVALUATION OF SEMI-SOLID FORMULATION: 
1. EVALUATION OF OINTMENT: 
PHYSIOCHEMICAL EVALUATION:  
  The formulated ointment  was evaluated for various physicochemical parameters. 
The colour of the ointment was dark green with characteristic odour. The 
physicochemical parameters observed are recorded in Table X. The results of viscosity 
and melting point are appreciable for ointment formulation. The result clearly indicated 
that the ointment showed good spreadability and extrudability. Spreadability expressed to 
denote of area to which the prepared formulations readily spread on application to skin 
and the extrudability is a measure of removal of the formulation through orifice of the 
container. The ointment showed a pH that lie in the normal pH range of human skin and 
is easily diffusible. 
Table X: Result of Physiochemical Evaluation of Ointment 
Parameters Observation 
Colour Dark green 
Odour Characteristic 
Loss on Drying 37%W/W 
pH 5.8 
Viscosity 16.05cps 
                  Melting Point 38
◦
C 
Spreadability(seconds) 12 
Extrudability 14.2g 
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HPTLC ANALYSIS: 
Table XI: Result of HPTLC Analaysis 
Sl.No Samples Maximum Rf % Area 
1 HMME 0.84 7.81 
2 Ointment containing 
2% MeOH.HMS 
0.83 9.85 
3 Quercetin 0.83 87.89 
              HMME- Hypericum mysorense methanolic extract 
  From the above result, it can be concluded that the methanolic extract of 
Hypericum   mysorense and the prepared ointment formulation contain quercetin as active 
ingredient. 
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IN-VITRO DIFFUSION STUDIES OF OINTMENT: 
CALIBRATION CURVE OF QUERCETIN: 
  Quercetin (50mg) was weighed accurately and dissolved in 50ml of methanol in 
50ml volumetric flask (stock –I). from this stock –I 1 ml solution was withdrawn and 
diluted to 10ml (Stock –II). From the stock –II solution serial dilutions were prepared by 
taking 0.2, 0.4, 0.6, 0.8, 1.0 and making the volume up to 10ml, which gives the 
concentrations of 2,4,6,8,10 µg/ml and the absorbance was noted at 369nm.  
                        Table XII: Caliberation Curve of Quercetin 
CONCENTRATION(µg/ml) ABSORBANCE 
0 0 
2 0.22 
4 0.456 
6 0.643 
8 0.908 
10 1.142 
 
Figure 10: Caliberation curve of Quercetin 
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Table XIII:  Result of in-vitro diffusion studies 
              % Cumulative Release 
Time(mins) Ointment containing 2% MeOH HMS  
30 18 
60 29 
90 43 
120 64 
150 69 
180 73 
 
Figure 11: Figure of in-vitro diffusion study 
                                 
 
KINETIC ANALYSIS: 
The in-vitro drug release studies were subjected to kinetic analysis by plotting 
various kinetic equations like zero order, first order, Higuchi plot. They were also 
subjected for peppas plot  in order to find out the mechanism of release from the 
prepared patches . The kinetic analysis data of the formulations were shown in table 
no XIII. 
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The data suggest that the formulation fit into first order equation for the release of 
drug  that depends mostly on diffusion characterstics.  
Table XIV: Release Kinetics of Formulated Ointment 
 
 
    Formulation 
Zero Order First Order Higuchi 
R2 R2 R2 n 
2% ointment 
containing 
MeOH.HMS 
0.925 0.966 0.939 0.837 
 
 
Figure 12: Zero Order Plot of Formulation 
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Figure 13: First Order Plot of Formulation 
 
 
 
Figure 14: Higuchi Plot of Formulation 
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STABILITY STUDIES: 
The purpose of stability testing is to provide evidence on how the quality of a drug 
substance or drug product varies with time under the influence of a variety of 
environmental factors such as temperature, humidity and light to establish shelf-life for 
the drug product and recommended storage conditions. 
 
Ointments at the concentrations of 2%,showed no changes in pH, viscosity, 
spreadability, extrudability, drug content after keeping at different temperatures for 
90days 
 
Table XV: Result of Stability Studies 
Sl.
No 
Formulation Temp Parameters 
   Colour viscosity Spreadabiliy extrudability MPt Assay 
1 
Oint 
cointaining 
2% extract 
(1st month) 
4◦ 
Dark 
green 
20.15 
cps 
8 5.7g 38◦ 
99.8% 
 25◦ 
Dark 
green 
16.05 
cps 
10 13.8g 38◦ 
 40◦ 
Dark 
green 
16.01 
cps 
12 14.2g 38◦ 
2 
Oint 
cointaining 
2% extract 
(2nd month) 
4◦ 
Dark 
green 
20.32 
cps 
7.5 5.5g 38◦ 
98.9%  25
◦ 
Dark 
green 
15.98 
cps 
No change No change 38◦ 
 40◦ 
Dark 
green 
15.95 
cps 
No change No change 38◦ 
3 Oint 
cointaining 
2% extract 
(3rd month) 
4◦ 
Dark 
green 
20.3cps 7.4 5.3g 38◦ 
98.5%  25◦ 
Dark 
green 
No 
change 
No change No change 38◦ 
  40◦ green 
No 
change 
No change No change 38◦ 
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E. PHARMACOLOGICAL EVALUATION OF THE FORMULATED 
OINTMENT: 
WOUND HEALING ACTIVITY:    
Table XVI:  Percentage Wound closure 
Test 
Compounds  
0
th
 day 3
rd
 day 7
th
 day 13
th
 day 17
th
 day 19
th
 day 
% WC % WC % WC % WC %WC %WC 
STD 0 15.7 ±0.29 39.8 ± 0.77 81.8 ± 1.09 88.5 ± 1.25 95.5 ± 1.10 
OINTMENT 
BASE 
0 13.5 ±0.49 27 ± 0.83 52.5 ± 1.24 66.8 ± 1.24 88.2 ± 1.88 
CONTROL 0 27.5 ± 0.58 23.6 ± 2.03 74.2 ± 0.99 72 ± 0.99 90.1 ± 0.99 
OINTMENT 
CONTAINING 
2%EXTRACT 
0 10 ± 0.42 13.8 ± 1.48 55.4 ± 1.08 84.1 ± 1.08 96.9 ± 1.08 
 
Results were expressed as mean (mm) ± SEM and were compared with the 
corresponding  control group (simple ointment B.P.) by applying ANOVA test. P value 
was set <0.05 for all analyses.  
Figure15: Figure showing percentage wound closure 
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                                    Table XVII: Figure showing percentage wound reduction 
Test 
compounds 
0
TH
 day 3
rd
 day 7
th
 day 13
th
 day 17
th
 day 19
th
 day 
%WR %WR %WR %WR %WR %WR 
     STD 100±0.00 84.3±0.29 60.2±0.77 18.2±1.09 11.5±1.25 4.42±1.10 
 OINTMENT 
BASE 
100±0.00 86.5±0.49 73±0.83 47.5±1.24 33.2±1.24 11.8±1.88 
CONTROL 100±0.00 72.5±0.58 76.4±2.03 25.8±0.99 28±0.99 9.81±0.99 
OINTMENT 
CONTAINING 
2% EXTRACT 
100±0.00 90±0.42 86.1±1.48 44.5±1.08 15.8±1.08 3.02±1.08 
 
Results were expressed as mean (mm) ± SEM and were compared with the 
corresponding  control group (simple ointment B.P.) by applying ANOVA test. P value 
was set <0.05 for all analyses 
                     Figure 16: Figure showing percentage wound reduction 
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Figure 17: Figure showing the wound healing activity from 0th day –– 21th day. 
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EXCISION WOUND ON 3RD DAY 
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                                             EXCISION WOUND ON 5TH  DAY 
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EXCISION WOUND ON 7TH  DAY 
 
 
                                                         
                                 
 
 
 
 
                  ONLY WOUND                                             WOUND + OINTMENT BASE 
 
 
                                                                     
              
WOUND + OINT CONTAINING 2% MeOH.HMS                    WOUND+ STANDARD 
 
                         
                                             
 Result & Discussion 
Dept of Pharmaceutics, KMCH College of Pharmacy Page 65 
 
 
 
EXCISION WOUND ON 9TH  DAY 
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EXCISION WOUND ON 17TH DAY 
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                                                EXCISION WOUND ON 19TH  DAY 
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EXCISION WOUND ON- 21ST DAY 
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Histopathological studies: 
The healing tissues obtained on the  3rd and 9th  day from the four groups of 
animals of the excision wound model were processed for histological study to determine 
the pattern of lay-down for collagen. The amount of collagen was quantified using 
Vangeison stain. 
Wound + Standard(3rd Day) 
Gross appearance: Received multiple tiny grey white soft tissue bits altogether 
measuring 0.6 x 0.4 x 0.3 cms. 
(AE): All embedded – one block. 
Microscopic appearance: Section studied from the skin shows acute ulcer with dense 
chronic inflammation composed of lymphocytes and plasma cells. No granulation tissue 
or fibrosis noted. 
WOUND + OINT CONTAINING 2% MeOH.HMS (3rd Day) 
Gross appearance: Received multiple tiny grey white soft tissue bits altogether 
measuring 0.7 x 0.4 x 0.2 cms. 
(AE): All embedded – one block. 
Microscopic appearance: Section studied from the skin shows dense chronic 
inflammation composed of lymphocytes and plasma cells with early stage of granulation 
tissue. And mild fibrosis also noted. 
Wound + Standard  (9th Day) 
Gross appearance: Received multiple tiny grey white soft tissue bits altogether 
measuring 1.0 x 0.5 x 0.3 cms. 
(AE): All embedded – one block. 
 
 Result & Discussion 
Dept of Pharmaceutics, KMCH College of Pharmacy Page 71 
 
 
Microscopic appearance: Section studied from the skin shows acute ulcer with 
granulation tissue with edema. Fibroblasts and papillary proliferation and mild fibrosis 
are seen. 
Wound + OINT CONTAINING 2% MeOH.HMS (9th Day) 
Gross appearance: Received multiple tiny grey white soft tissue bits altogether 
measuring 0.9 x 0.4 x 0.4 cms. 
(AE): All embedded – one block. 
Microscopic appearance: Section studied from the skin shows granulation tissue with 
dense chronic inflammation along with scattered fibroblasts and proliferating papillae. 
Figure 18: 3rd day microscopical view of the wound tissue 
                                         
  STANDARD                             OINT CONTAINING 2% MeOH.HMS 
                     Figure 19: 9th day microscopical view of the wound tissue 
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INFERENCE: 
The 2% concentration of the methanolic extract ointment showed significant 
responses in excision wound model when compared with the control group. The effect 
produced by the extract ointment, in terms of wound contracting ability, wound closure 
time, regeneration of tissues at wound site, and histopathological characteristics were 
comparable to those of a standard drug, Povidone Iodine ointment. 
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SUMMARY 
 Hypericum mysorense is an ornamental plant belonging to the family 
Hypericaceae, having antibacterial activity, against both gram-positive and gram-negative 
bacteria. Leaf and flower have strong antioxidant potential and used for liver disorders. 
Its stem is having strong antitumor, antipsychic and antiviral activities. Among the 
various indications where traditional herbal medicines are used, skin and skin related 
disorders are ranked top. Thus, the main objective of the present study is to formulate and 
evaluate semi-solid dosage forms of Hypericum mysorense for its wound healing activity. 
 
FORMULATION: 
   The stem of Hypericum mysorense was extracted by continuous hot percolation/ 
soxhletation using methanol as solvent and was evaluated for its phytochemical property, 
in-vitro antimicrobial and in-vitro antioxidant activity. Using this methanolic extract, 
semi-solid dosage form (ointment) was formulated. Ointment was prepared with 2% 
methanolic extract using emulsifying ointment base. 
 
EVALUATION: 
  The methanolic extract was evaluated for its in-vitro antimicrobial and antioxidant 
properties using disc diffusion method and DPPH, FRAP analysis respectively. The 
results suggested that the plant possess activity comparable to the standard, ciprofloxacin 
(anti-bacterial), clotrimazole(anti-fungal) and ascorbic acid (anti-oxidant). Further, the 
formulated ointment was evaluated for their physiochemical properties like colour, pH, 
viscosity, melting point, spreadability, extrudability etc. HPTLC analysis, in-vitro 
diffusion studies, release kinetics and stability studies were also conducted on the 
preparation. The results of in-vitro antimicrobial and in-vitro antioxidant activity added 
on to the wound healing activity of the extract. Hence, the ointment containing 2% 
Methanolic Extract of Hypericum mysorense stem was evaluated for its wound healing 
activity using excision wound model. The formulation did not produce any skin irritation 
for about a week when applied over the skin. Wister rats weighing around 150-200g were 
used for the study. They were divided into 4 groups consisting of 6 rats each. The 4 
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groups include standard(povidone iodine ointment), control( only wound),rats treated 
with ointment base and rats treated with 2% ointment. The effect produced by the extract 
ointment, in terms of wound contracting ability, wound closure time and 
histopathological characteristics were comparable to that of a standard drug, povidone 
iodine ointment. Thereby, the ointment formulated using 2% methanolic extract of 
Hypericum mysorense was found to possess wound healing activity. 
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CONCLUSION 
 
 Methanolic extract of Hypericum mysorense was prepared by continous hot 
percolation and was evaluated for its phytochemical property, in-vitro antimicrobial 
and in-vitro antioxidant activity.  
 
 Using this methanolic extract, semi-solid dosage form (ointment) was formulated. 
Ointment were prepared with 2% methanolic extract using emulsifying ointment 
base and was then screened for its physiochemical property,HPTLCanalysis, in-vitro 
drug diffusion,kinetic studies and stability studies. The results of in-vitro 
antimicrobial and in-vitro antioxidant activity added on to the wound healing activity 
of the extract.  
 
 Hence, the 2% ointment was evaluated for its wound healing activity using excision 
wound model. The effect produced by the extract ointment, in terms of wound 
contracting ability, wound closure time and histopathological characteristics were 
comparable to that of a standard drug, povidone iodine ointment. 
 
 Therefore, the present study concluded the wound healing activity of Hypericum 
mysorense stem at 2% concentration of the methanolic extract formulated as an 
ointment. 
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ABBREVIATIONS
• MeOH HMS     Methanolic extract of Hypericum            
mysorense
• Oint Ointment
• MP                   Melting point
• % Percentage
• gm. gram
• mg. Milligram
• μg. Micro gram
• ml. Millilitre
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• nm. Nanometer
• W/W Weight by weight
• W/V            Weight by volume
• pH. Hydrogen ion concentration
• oC Degree centigrade
• RPM. Revolution per minute
• Abs. Absorbance
• Conc. Concentration
• CR Cumulative Release
• R2                        Regression coefficient
INTRODUCTION
 The majority of the populations in the developing world rely 
on traditional medicine for their primary healthcare needs. 
Herbal therapy predominates in traditional medicine as well as 
in complementary or alternative medicine practiced in the 
developed world.
 Hypericum mysorense is a medicinal plant having 
antibacterial , antioxidant, antitumor, antipsychic and antiviral 
activities.
 Thus, the main objective of the present study is to formulate 
and evaluate ointment form of Hypericum mysorense for its 
wound healing activity.
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Wound healing involves a complex series of interactions 
between different cell types, cytokine mediators, and the 
extracellular matrix. 
 The phases of normal wound healing include 
haemostasis, inflammation, proliferation and remodeling. 
 The properties leading to wound healing includes anti-
oxidant, anti-inflammatory, anti- microbial ,analgesic 
activity.
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AIM AND OBJECTIVE
The aim of the present study is to highlight the use of 
Hypericum mysorense for the treatment of cuts and wounds as 
a wound healer. The study involves the formulation and 
evaluation of methanolic extract of Hypericum mysorense as a 
ointment form for its wound healing activity.
The objective of the study was:
• To carry out continuous hot percolation of Hypericum 
mysorense using methanol as solvent.
• To evaluate phytochemical constituents of the obtained 
methanolic extract of Hypericum mysorense.
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• To evaluate the methanolic extract of Hypericum mysorense
for its in-vitro antioxidant and antimicrobial property.
• To formulate methanolic extract of Hypericum mysorense
as semi-solid dosage form(ointment).
• To evaluate the physiochemical parameter of the formulated 
ointment.
• To conduct HPTLC analysis, in-vitro diffusion studies, 
release kinetics and stability studies of the prepared 
ointment
• To assess the wound healing property of the prepared 
herbal ointment by excision wound model.
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LITERATURE REVIEW
Sl No Author’s       
name
Journal Name Objective Conclusion
1 Pulok K 
Mukerjee et 
al 
Natural
Product 
Sciences, 
6(2):73-
78(2000)
Studied in-vivo wound 
healing activity of leaf 
extract of Hypericum 
mysorense(5%,10%) 
with different wound 
model in rats.
Both the concentrations 
of methanolic extract 
ointment showed 
significant response 
when compared with 
control group
2 Shanmugam
Moorthy et 
al
Reasearch
Journal of 
Biotechnology, 
Vol 5, (1),Feb 
(2010)
Studied the effect of 
ethanolic extract of 
Hypericum mysorense 
on anti-oxidant and 
anti-depressant activity.
Indicates anti-oxidant 
and anti-depressant 
effect of ethanolic
extract of Hypericum 
mysorense.
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Sl No Author’s 
Name
Journal Name Objective Conclusion
3 P Vijayan, 
C Raghu et 
al 
Indian Journal 
of Medical 
Research, 
120,July 
2004,pg 24-29
Screened various plant 
extracts  for antiviral 
properties by 
cytopathic effect 
inhibition assay and 
virus yield reduction 
assay.
Hypericum mysorense 
exhibited  significant
antiviral activity.
4 Atul
Murlidhar
Wahile
Thesis
submitted for 
the degree of 
Doctor of 
Philosophy(Ph
armacy) of 
Jadavpur
University,cha
pter 10,11
Investigated the 
analgesic potential of 
ethyl acetate and 
methanolic extract of 
Hypericum mysorense 
through hot plate 
method and acetic acid 
induced writhing test 
in mice.
Hypericum mysorense 
showed analgesic 
activity.
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PLANT PROFILE
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DESCRIPTION OF PLANT’S BOTANICAL 
INFORMATION:
Botanical name          : Hypericum mysorense                                      
Family                        :  Hypericaceae
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MEDICINAL USES: 
• It is an ornamental plant having antibacterial activity, 
active against both gram-positive and gram-negative 
bacteria.
• Leaf and flower have strong antioxidant potential and 
used for liver disorders.
• Its stem is having strong antitumor, antipsychic and 
antiviral activities.
METHODOLOGY
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1. EXTRACTION(CONTINUOUS HOT PERCOLATION)
200 g of powdered stem of 
Hypericum mysorense was 
defatted using petroleum 
ether.
Marc obtained was extracted 
with 250 ml of methanol for 
48 hrs by using soxhlet
apparatus
Solvent is distilled out and 
concentrated residue is 
analysed by chemical test
2. INVITRO ANTIMICROBIAL STUDIES
• Antibacterial screening
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Sl no Organisms used standard test Control
Gram positive Gram 
negative
1 Bacillus subtilis Escherichia
coli
Ciprofloxacin
10µg
Methanolic 
extract of 
Hypericum 
mysorense
stem
Plain 
sterile
disc
2 Staphylococcus 
aureus
Salmonella 
paratyphi
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• Antifungal screening
Sl no Organism Standard Test Control
1 Candida 
albicans
Clotrimazole
10µg
Methanolic 
extract of 
Hypericum 
mysorense
stem
Plain 
sterile
disc
2 Aspergillus
niger
3.INVITRO ANTIOXIDANT STUDIES
• DPPH assay:
0.3mM solution of DPPH in methanol was prepared and 1ml 
of this solution was added to 1ml of various concentrations of 
sample and the reference compound (10, 20, 30, 40 and 50 
µg/ml), were shaken vigorously and left to stand in the dark at 
room temperature for 30 min and then absorbance was 
measured at 517 nm. A control reaction was carried out 
without the test sample. All the tests were performed in 
triplicate in order to get the mean values. The percentage of 
inhibition was calculated by comparing the absorbance values 
of the control and test samples. 
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Antiradical activity was expressed as inhibition percentage (I %) 
and calculated using the following equation:
Inhibition percentage (I %) = (Abscontrol- Abssample/Abscontrol) X 100
• FRAP assay:
To 900 µl of FRAP reagent add different concentrations of sample 
solution (10, 20, 30, 40 and 50 µg/ml) and the final volume was 
made up to 1ml. 
The increase in absorbance at 593 nm was measured at 4 min. 
FeSO4.7H2O was used as a standard. FRAP value was expressed as 
mmol/100 g on dry weight basis using the calibration curve of 
Fe2+.
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4.COMPOSITION OF OINTMENT:
SL.NO INGREDIENTS F1
1 Methanolic Extract of 
Hypericum mysorense
2gm
2
Emulsifying 
Ointment(Emulsifying wax ,                
White soft paraffin ,
Liquid paraffin )
q.s to 100gm
5. EVALUATION OF OINTMENT
• Physiochemical Evaluation:
The physiochemical properties such as colour, loss on drying, 
pH, viscosity, melting point, spreadability and extrudability 
were analysed.
• HPTLC analysis:
Stationary phase : HPTLC plate silica gel 60F 254(10×10cm)   
Mobile phase     : Toluene:ethyl acetate:formic acid:methanol
(3:6:1.6:0.4) 
The percentage of active ingredient(quercetin) present in 
the ointment containing 2% methanolic extract was compared 
with that of standard.
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• Invitro drug diffusion study(Franz diffusion cell)
Synthetic cellophane membrane was mounted between 
donor and receptor compartment.
The formulated ointment was placed over the drug 
release membrane and the receptor compartment was 
filled with phosphate buffer pH=7.4
The whole assembly was fixed on magnetic stirrer(50 
rpm)
2ml sample withdrawn at 30,60,90,120,150 and 180 
mins.
Analysed spectrophotometrically at 369 nm.
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• Release Kinetics:
To study the release kinetics, data obtained from in vitro
drug release studies were plotted. In various kinetic models: 
zero order (Equation 1) as cumulative amount of drug 
released Vs. time, first order (Equation 2) as log cumulative 
percentage of drug remaining vs. time, And Higuchi’s 
model (Equation 3) as cumulative percentage of drug 
released vs. squareroot of time.
C = K0 t                     (1)
LogC = LogCo−kt/2.303 (2)
Q = Kt1/2                                 (3)
Department of Pharmaceutics 22
• Stability Studies:
The stability studies were carried out in formulation at 
different temperature conditions (4,25 and 40◦C) for 3 
months. 
All the evaluation parameters i.e. pH, viscosity, melting 
point, spreadability and extrudability were studied at 
different time intervals i.e.30th, 60th and 90th day.
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• Pharmacological Evaluation 
Excision Wound Model
Group Treatment:dose and 
route of administration
Number of 
animals
1 Group treated with simple 
ointment base
6
2 Control group with only 
wound
6
3 Standard group treated 
with povidone iodine 
ointment
6
4 Ointment containing 2% 
MeOH.HMS
6
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Animals:
Species : adult Wistar rats
Weight : 150 – 200 gms
Gender : male
Number to be used : 24
Route of Induction : Topical application
Duration : 21 days
RESULTS AND DISCUSSION
1. PHYTOCHEMICAL ANALYSIS: 
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CONSTITUENTS TEST INFERENCE
Carbohydrates Molisch’s ,Fehling’s, Benedict’s, Barfoed’s Absent
Glycosides Legal, Borntrager’s Absent
Alkaloids Mayer’s, Dragendroff’s, Wagner’s, Hager’s Present
Flavanoids Ferric chloride, Shinoda’s Present
Proteins Biuret, Ninhydrin, Millon’s Absent
Tannins Ferric chloride, Lead acetate Present
Saponins Foam test Present
Steroids Liebermann- Burchard, Salkowski Present
2. INVITRO ANTIMICROBIAL STUDIES
• Antibacterial Screening by Disc Diffusion Method:
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Extract Used
Diameter of
Zone of inhibition
(mm)
Gram +ve Bacteria Gram  -ve Bacteria
B.subtilis S.aureus E. coli S.paratyphi
Ciprofloxacin 31 29 26 13
MeOH.HMS 15 14 12 10
Control 8 7 9 8
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• Antifungal Screening by Disc Diffusion Method
Extract Used Diameter of  Zone of
Inhibition (mm)
Candida albicans Aspergillus niger
Clotrimazole 30 32
MeOH. HMS 15 16
Control 7 7
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3.  INVITRO ANTIOXIDANT STUDIES:
DPPH Assay
0
10
20
30
40
50
60
70
80
90
100
5
10
15
20
25
%inhibition
MeOH.HMS
%inhibition
ascorbic acid
conc(µg/ml)
CONC(µg/ml)
% INHIBITION
MeOH. HMS ASCORBIC 
ACID
5
43.22±0.15 49.76±0.16
10
53.07±0.17 53.08±0.17
15
65.77±0.16 69.47±0.18
20
78.33±0.15 88.42±0.14
25
95.33±0.13 98.75±0.13
EC 50 9.4±0.13 9.4±0.15
FRAP assay
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CONC.  
(µg/ml)
ABSORBANCE
MeOH.HMS
ASCORBIC 
ACID
20 0.8287 1.2788
40 1.3264 1.5477
60 1.7279 1.8804
80 2.0407 2.1987
100 2.195 2.4273
0
0.5
1
1.5
2
2.5
20 40 60 80 100
MeOH.HMS
Ascorbic Acid
conc(µg/ml)
ab
so
rb
an
ce
4.  EVALUATION OF OINTMENT:
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•Physiochemical Evaluation
Parameters Observation
Colour Dark green
Odour Characteristic
pH 5.8
Viscosity 16.05cps
Melting point 38
◦C
Spreadability(seconds) 12
Extrudability 14.2g
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• HPTLC Analysis:
Sl.No Samples Maximum Rf % area
1 HMME 0.84 7.81
2 Ointment 
containing 2% 
MeOH.HMS
0.83 9.85
3 Quercetin 0.83 87.89
HMME- Hypericum mysorense methanolic extract
From the above result, it can be concluded that the 
methanolic extract of Hypericum   mysorense and the 
prepared ointment formulation contain quercetin as 
active ingredient.
• In-vitro Diffusion Studies:
Department of Pharmaceutics 32
%drug release
Time (secs) Ointment containing 
2% MeOH HMS 
30 18
60 29
90 43
120 64
150 69
180 73
0
10
20
30
40
50
60
70
80
0 100 200
ointment
containing 2%
MeOH.HMs
%
CR
Time (secs)
• Drug Release Kinetic Analysis :
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Formulation
Zero order First order Higuchi model
R
2
R
2
R
2
n
2% Ointment containing
methanolic extract 
0.925 0.966 0.939 0.837
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y = -0.0035x + 2.0356
R² = 0.9669
0
0.5
1
1.5
2
2.5
0 50 100 150 200
Series1
Linear (Series1)
FIRST ORDER 
KINETICS
The data suggest that the formulation fit into first order 
equation for the release of drug  that depends mostly on 
diffusion characterstics
•Stability Studies:
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Sl.No Formulation Temp Parameters
Colour viscosity Spreadabiliy extrudability MPt Assay
1
Oint cointaining 
2% extract
(1st month)
4◦ Dark green
20.15
cps
8 5.7g 38◦
99.8%
25◦ Dark green
16.05
cps
10 13.8g 38◦
40◦ Dark green 16.01 cps 12 14.2g 38◦
2
Oint cointaining 
2% extract
(2nd month)
4◦ Dark green
20.32
cps
7.5 5.5g 38◦
98.9%25◦ Dark green
15.98
cps
No change No change 38◦
40◦ Dark green
15.95
cps
No change No change 38◦
3 Oint cointaining 
2% extract
(3rd month)
4◦ Dark green 20.3cps 7.4 5.3g 38◦
98.5%25◦ Dark green No change No change No change 38◦
40◦ green No change No change No change 38◦
Figure showing the wound healing activity from 0thday –– 21th
day.
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EXCISION WOUND ON 0TH DAY
ONLY WOUND                                                             WOUND + OINTMENT BASE
WOUND + OINT CONTAINING 2% MEOH.HMS WOUND + STANDARD
EXCISION WOUND ON 3RD DAY
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ONLY WOUND WOUND + OINTMENT BASE
WOUND + OINT CONTAINING 2% MEOH.HMS WOUND + STANDARD
EXCISION WOUND ON 5TH DAY
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ONLY WOUND WOUND + OINTMENT BASE
WOUND + OINT CONTAINING 2%  MEOH.HMS WOUND + STANDARD
EXCISION WOUND ON 7TH DAY
Department of Pharmaceutics 39
ONLY WOUND WOUND + OINTMENT BASE
WOUND+ OINT CONTAINING 2%  MEOH.HMS WOUND+ STANDARD
EXCISION WOUND ON 9TH DAY
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ONLY WOUND                                                      WOUND+OINTMENT BASE
WOUND + OINT CONTAINING 2%  MEOH.HMS WOUND + STANDARD
EXCISION WOUND ON 13TH DAY
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ONLY WOUND                                                WOUND+ OINTMENT BASE   
WOUND + OINT CONTAINING 2%  MEOH.HMS WOUND+ STANDARD
EXCISION WOUND ON 17TH DAY
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ONLY WOUND WOUND+ OINTMENT BASE
WOUND + OINT CONTAINING 2%  MEOH.HMS WOUND + STANDARD
EXCISION WOUND ON 19TH DAY
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ONLY WOUND                                       WOUND + OINTMENT BASE
WOUND + OINT CONTAINING 2%  MEOH.HMS WOUND+ STANDARD
EXCISION WOUND ON 21ST DAY
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ONLY WOUND                                                   WOUND + OINTMENT BASE      
WOUND + OINT CONTAINING 2%  MEOH.HMS WOUND+ STANDARD
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•Wound Healing Activity: 
Percentage wound closure
Test Compounds 
0th day 3rd day 7th day 13th day 17th day 19th day
% WC % WC % WC % WC %WC %WC
STD 0 15.7 ±0.29 39.8±0.77 81.8±1.09 88.5±1.25 95.5±1.10
OINTMENT 
BASE
0 13.5 ±0.49 27±0.83 52.5±1.24 66.8±1.24 88.2±1.88
CONTROL 0 27.5±0.58 23.6±2.03 74.2±0.99 72±0.99 90.1±0.99
OINTMENT 
CONTAINING 
2%EXTRACT
0 10±0.42 13.8±1.48 55.4±1.08 84.1±1.08 96.9±1.08
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Percentage Wound Reduction
Test compounds
0TH day 3rd day 7th day 13th day 17th day 19th day
%WR %WR %WR %WR %WR %WR
STD 100±0.00 84.3±0.29 60.2±0.77 18.2±1.09 11.5±1.25 4.42±1.10
OINTMENT 
BASE
100±0.00 86.5±0.49 73±0.83 47.5±1.24 33.2±1.24 11.8±1.88
CONTROL 100±0.00 72.5±0.58 76.4±2.03 25.8±0.99 28±0.99 9.81±0.99
OINTMENT 
CONTAINING 2% 
EXTRACT
100±0.00 90±0.42 86.1±1.48 44.5±1.08 15.8±1.08 3.02±1.08
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Figure showing percentage wound closure Figure showing percentage wound reduction
0
20
40
60
80
100
120
0 10 20 30
STANDARD
OINTMENT BASE
CONTROL
OINT
CONTAINING 2%
MeOH.HMS 0
20
40
60
80
100
120
0 10 20 30
STANDARD
OINTMENT
BASE
CONTROL
OINT
CONTAINING
2% MeOH.HMS
NO OF DAYS
% WR
%  
WC
NO OF DAYS
•Histopathological Studies:
3rd day microscopical view of the wound tissue
STANDARD                OINT CONTAINING 2% MeOH.HMS
Microscopic appearance: Section studied from the skin shows 
dense chronic inflammation composed of lymphocytes and 
plasma cells with early stage of granulation tissue. And mild 
fibrosis also noted.
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9th day microscopical view of the wound tissue
STANDARD                     OINT CONTAINING 2% MeOH.HMS
Microscopic appearance: Section studied from the skin shows 
granulation tissue with dense chronic inflammation along with 
scattered fibroblasts and proliferating papillae.
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CONCLUSION
Methanolic extract of Hypericum mysorense was prepared by
continous hot percolation and was evaluated for its
phytochemical property, in-vitro antimicrobial and in-vitro
antioxidant activity. Using this methanolic extract, semi-solid
dosage form (ointment ) were formulated.
 Ointment were prepared with 2% methanolic extract using
emulsifying ointment base. Both the formulations were then
screened for its physiochemical property,HPTLCanalysis, in-
vitro drug diffusion,kinetic studies and stability studies .
The results of in-vitro antimicrobial and in-vitro antioxidant
activity added on to the wound healing activity of the extract.
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Hence, the 2% ointment was evaluated for its wound
healing activity using excision wound model. The effect
produced by the extract ointment, in terms of wound
contracting ability, wound closure time and histopathological
characteristics were comparable to that of a standard drug,
povidone iodine ointment.
 Therefore, the present study concluded the wound healing
activity of Hypericum mysorense at 2% concentration of the
methanolic extract formulated as an ointment.
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Comment
Pre-conditioning
Mobile phase TOLUENE:ETHYL ACETATE:FORMIC
ACID:METHANOL(3:6:1.6:0.4)
Solvent front position 70.0 mm
Volume 10.0 ml
Drying device Oven
Temperature 60 °C   
Time 5 Minutes   
Notes
Detection - CAMAG TLC Scanner 3
Information
Application position  10.0 mm
Solvent front position  70.0 mm
  
Instrument CAMAG TLC Scanner 3 "Scanner3_170310" S/N 170310 (1.14.28)
Executed by KMCHCOP                   Tuesday, January 28, 2014 7:01:43 PM
Number of tracks 10
Position of first track X  10.0 mm
Distance between tracks   8.8 mm
Scan start pos. Y   5.0 mm
Scan end pos. Y  75.0 mm
Slit dimensions  5.00 x 0.45 mm, Micro
Optimize optical system Light
Scanning speed:  20 mm/s
Data resolution: 100 µm/step
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Measurement Table
Wavelength 254
Lamp D2 & W
Measurement Type Remission
Measurement Mode Absorption  
Optical filter Second order
Detector mode Automatic
PM high voltage 273 V
  
Detector properties
Y-position for 0 adjust   5.0 mm
Track # for 0 adjust 0
Analog Offset 10%
Sensitivity Automatic (41)
Integration
Properties
Data filtering Savitsky-Golay 7
Baseline correction Lowest Slope
Peak threshold min. slope 5
Peak threshold min. height 10 AU
Peak threshold min. area 50
Peak threshold max. height 990 AU
Track start position 8.9 mm
Track end position 66.8 mm
Display scaling Automatic
All tracks at Wavelength
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  Track 1, ID: TGEAE
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Start
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Height
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Height
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%
End
Rf
End
Height Area
Area
% Assigned substance
1 -0.00    2.9  0.01  210.3  32.79  0.09   43.2    4535.2  21.50 unknown *
2  0.11   44.0  0.13   52.3   8.16  0.18   31.6    1943.8   9.21 unknown *
3  0.20   31.5  0.27  204.1  31.83  0.36   14.5    7250.7  34.37 unknown *
4  0.80    0.3  0.87  174.5  27.22  0.94    8.4    7364.6  34.91 unknown *
  Track 2, ID: APIGENIN
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1 -0.00    0.8  0.01   66.6  10.50  0.05    9.1     852.7   6.22 unknown *
2  0.42    2.3  0.48   37.6   5.92  0.52    6.3    1300.1   9.49 unknown *
3  0.79    3.8  0.87  530.2  83.58  0.94    0.3   11549.3  84.29 unknown *
  Track 3, ID: TGEE
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Peak
Start
Rf
Start
Height
Max
Rf
Max
Height
Max
%
End
Rf
End
Height Area
Area
% Assigned substance
1 -0.00    6.1  0.01  528.3  41.90  0.07   94.5    9041.7  30.89 unknown *
2  0.07   95.1  0.11  368.5  29.23  0.16   57.8    9742.4  33.28 unknown *
3  0.16   58.1  0.18   65.8   5.22  0.24   32.6    2717.2   9.28 unknown *
4  0.25   32.7  0.26   38.1   3.02  0.29   24.2     974.2   3.33 unknown *
5  0.32   27.0  0.35   36.6   2.90  0.38   20.3    1166.5   3.99 unknown *
6  0.43   20.3  0.45   29.6   2.35  0.50    4.8     774.4   2.65 unknown *
7  0.53    6.8  0.54   13.1   1.04  0.58    3.2     235.0   0.80 unknown *
8  0.73    1.7  0.78   19.7   1.56  0.80   14.4     421.5   1.44 unknown *
9  0.80   14.6  0.85   75.6   6.00  0.87   68.7    2056.0   7.02 unknown *
10  0.87   68.9  0.89   85.5   6.78  0.94    3.8    2141.2   7.32 unknown *
  Track 4, ID: HMME
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Area
% Assigned substance
1 -0.01    0.3  0.01  805.7  35.68  0.12   99.5   17296.7  28.08 unknown *
2  0.15   77.6  0.17   79.1   3.50  0.19   65.7    1727.6   2.80 unknown *
3  0.19   65.9  0.28  393.5  17.43  0.32  147.4   14489.1  23.52 unknown *
4  0.32  149.3  0.34  204.0   9.03  0.43   33.5    8627.6  14.01 unknown *
5  0.44   34.8  0.51  278.2  12.32  0.56    0.2    8794.8  14.28 unknown *
6  0.67    0.3  0.72   33.5   1.48  0.75   24.7    1246.1   2.02 unknown *
7  0.77   30.2  0.81  208.5   9.23  0.82  164.9    4375.5   7.10 unknown *
8  0.83  166.9  0.84  228.9  10.13  0.90    0.4    4810.5   7.81 unknown *
9  0.92    0.5  0.94   26.8   1.19  0.94   23.3     227.4   0.37 unknown *
  Track 5, ID: RUTIN
-0.17 0.03 0.23 0.43 0.63 0.83 1.03
0
100
200
300
400
500
600
-0.17 0.03 0.23 0.43 0.63 0.83 1.03
0
100
200
300
400
500
600
TANNIC ACID @ 254 nm2
3
4 5 6 7
winCATS Planar Chromatography Manager
User : KMCHCOP                                    Approved :. . . . . . . . . . . . . . . . . . . SN 1705W004, V1.4.4
Tuesday, January 28, 2014 7:07:57 PM              Report ID : 07DE011C0313062A  Page 6 of 12
Peak
Start
Rf
Start
Height
Max
Rf
Max
Height
Max
%
End
Rf
End
Height Area
Area
% Assigned substance
1 -0.01    0.5  0.01  119.1  17.17  0.02  105.6    1217.9   8.84 TANNIC ACID
2  0.02  106.7  0.03  129.7  18.70  0.06   11.4    1483.9  10.77 unknown *
3  0.08    9.4  0.16  381.1  54.94  0.20    6.8    9797.4  71.11 unknown *
4  0.21    7.2  0.23   15.4   2.22  0.27    0.3     290.4   2.11 unknown *
5  0.33    0.9  0.37   14.1   2.03  0.41    0.0     319.8   2.32 unknown *
6  0.69    4.6  0.74   15.2   2.20  0.77   10.2     453.4   3.29 unknown *
7  0.77    8.2  0.78   19.0   2.74  0.80    1.0     215.5   1.56 unknown *
  Track 6, ID: QUERCETIN
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1 -0.01    0.7  0.01   39.6   4.76  0.03    3.6     390.4   2.25 unknown *
2  0.14    1.2  0.17   14.6   1.76  0.20    1.4     256.0   1.47 unknown *
3  0.32    5.2  0.36   17.3   2.08  0.37   15.3     399.1   2.30 unknown *
4  0.40   15.2  0.41   16.8   2.02  0.44    0.5     200.7   1.16 unknown *
5  0.69    6.8  0.73   26.0   3.13  0.74   23.6     498.9   2.87 unknown *
6  0.74   23.7  0.75   36.4   4.38  0.76   26.1     357.2   2.06 unknown *
7  0.76   26.6  0.83  680.4  81.86  0.89    5.4   15257.9  87.89 unknown *
  Track 7, ID: 2% OINTMENT
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Peak
Start
Rf
Start
Height
Max
Rf
Max
Height
Max
%
End
Rf
End
Height Area
Area
% Assigned substance
1 -0.02    0.8  0.01  685.0  35.98  0.09  119.2   15821.6  29.62 unknown *
2  0.21   56.0  0.28  324.0  17.02  0.31  135.3   11339.5  21.23 unknown *
3  0.32  135.7  0.34  175.8   9.23  0.42   25.3    7657.4  14.33 unknown *
4  0.43   26.1  0.51  232.9  12.24  0.56    2.0    7314.5  13.69 unknown *
5  0.64    0.3  0.70   27.1   1.42  0.74   17.4    1050.6   1.97 unknown *
6  0.74   17.8  0.80  204.3  10.73  0.81  163.8    4772.7   8.93 unknown *
7  0.81  165.3  0.83  237.6  12.48  0.90    0.6    5264.1   9.85 unknown *
8  0.91    0.5  0.93   16.9   0.89  0.94   12.3     202.3   0.38 unknown *
  Track 8, ID: TANNIC ACID
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1 -0.00    0.3  0.02   49.9   4.11  0.05   28.2     914.9   2.71 unknown *
2  0.12   39.7  0.23  202.5  16.68  0.26  114.0    8024.8  23.80 unknown *
3  0.26  115.4  0.30  347.3  28.60  0.40    3.8   11607.0  34.43 unknown *
4  0.54    1.8  0.58   14.2   1.17  0.59   11.3     237.6   0.70 unknown *
5  0.68   10.9  0.72  147.9  12.18  0.76   22.3    3506.6  10.40 unknown *
6  0.76   23.3  0.80  452.6  37.27  0.84    1.6    9423.2  27.95 unknown *
  Track 9, ID: TCEAE
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1  0.00    0.0  0.01   27.1  13.65  0.05    8.8     377.7   9.48 unknown *
2  0.53    1.5  0.55   10.5   5.27  0.57    0.5     123.4   3.10 unknown *
3  0.79    1.1  0.84   46.8  23.55  0.85   32.6     984.2  24.71 unknown *
4  0.85   32.7  0.89  114.3  57.53  0.94    3.5    2498.2  62.71 unknown *
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  Track 10, ID: TGEE
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1  0.00    1.5  0.02  571.0  43.81  0.08  123.5   12246.2  29.89 unknown *
2  0.09  123.5  0.11  129.7   9.95  0.19   81.6    6499.1  15.86 unknown *
3  0.19   81.7  0.26  384.8  29.53  0.33   48.5   13471.9  32.88 unknown *
4  0.37   39.1  0.38   40.2   3.09  0.42   18.3    1110.5   2.71 unknown *
5  0.43   18.4  0.45   25.4   1.95  0.48   11.2     624.8   1.52 unknown *
6  0.48   10.5  0.49   12.6   0.97  0.56    0.1     326.9   0.80 unknown *
7  0.69    1.9  0.74   16.5   1.27  0.76    8.8     414.0   1.01 unknown *
8  0.76    8.9  0.84  123.0   9.44  0.94    0.3    6279.9  15.33 unknown *
Spectrum scan
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Mode All detected peaks
Slit dimensions  5.00 x 0.45 mm, Micro
Optimize optical system Resolution
Scanning speed 100 nm/s
Data resolution  1 nm/step
Reference spectrum, pos X  10.0 mm
Reference spectrum, pos Y  10.0 mm
  
Measurement Table
Lamp D2 & W
Start wavelength 200 nm
End wavelength 400 nm
Measurement type Remission
Measurement Mode Absorption  
Optical filter Second order
Detector Mode Automatic
  
Detector properties
Y-position for 0 adjust   0.0 mm
Track # for 0 adjust 0
Analog Offset 10%
Sensitivity Automatic (31)
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RUTIN on all Tracks
400.0300.0250.0200.0 [ nm ]
100.0
 80.0
 70.0
 60.0
 50.0
 40.0
 30.0
 20.0
 10.0
  0.0
[ AU ]
100.0
 80.0
 70.0
 60.0
 50.0
 40.0
 30.0
 20.0
 10.0
  0.0
[ AU ]
 T Rf Substance Max. @
QUERCETIN on all Tracks
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APIGENIN on all Tracks
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TANNIC ACID on all Tracks
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5  0.01 Rf TANNIC ACID 364 nm
Evaluation results
Evaluation Sequence
Track Track type Vial Sample ID
1 Sample 1 TGEAE
2 Sample 2 APIGENIN
3 Sample 3 TGEE
4 Sample 4 HMME
5 Sample 5 RUTIN
6 Sample 6 QUERCETIN
7 Sample 7 2% OINTMENT
8 Sample 8 TANNIC ACID
9 Sample 9 TCEAE
10 Sample 10 TGEE
Table of substances
Position Tracks 1
Substance MD mm 1 2 3 4 5 6 7 8 9 0
RUTIN  10.0
QUERCETIN  10.0
APIGENIN  10.0
TANNIC ACID  10.0 A
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Image name IMG_7208
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Created by KMCHCOP on Tuesday, January 28, 2014 7:05:00 PM
Image ID 52E7B204
Image Document
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Image name IMG_7209
Created by KMCHCOP on Tuesday, January 28, 2014 7:05:54 PM
Image ID 52E7B23A
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Image Document
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Image name IMG_7211
Created by KMCHCOP on Tuesday, January 28, 2014 7:06:38 PM
Image ID 52E7B266
